Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cysteine-type deubiquitinase activity	USP17L2 USP17L20 USP17L11 USP17L24 USP24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	2.97e-12	114	149	13	GO:0004843
GeneOntologyMolecularFunction	deubiquitinase activity	USP17L2 USP17L20 USP17L11 USP17L24 USP24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	8.83e-12	124	149	13	GO:0101005
GeneOntologyMolecularFunction	ubiquitin-like protein peptidase activity	USP17L2 USP17L20 USP17L11 USP17L24 USP24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	3.17e-11	137	149	13	GO:0019783
GeneOntologyMolecularFunction	cysteine-type peptidase activity	USP17L2 USP17L20 USP17L11 USP17L24 USP24 USP17L5 USP17L19 USP17L18 ADGB USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	1.87e-10	192	149	14	GO:0008234
GeneOntologyMolecularFunction	peptidase activity	USP17L2 USP17L20 USP17L11 USP17L24 USP24 USP17L5 USP17L19 USP17L18 ADGB USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	3.96e-04	654	149	14	GO:0008233
GeneOntologyMolecularFunction	SUMO ligase activity	RGPD4 RGPD1 RGPD3	4.23e-04	20	149	3	GO:0061665
GeneOntologyMolecularFunction	peptidyl-prolyl cis-trans isomerase activity	RGPD4 RGPD1 RGPD3 NKTR	5.25e-04	50	149	4	GO:0003755
GeneOntologyMolecularFunction	cis-trans isomerase activity	RGPD4 RGPD1 RGPD3 NKTR	6.56e-04	53	149	4	GO:0016859
GeneOntologyBiologicalProcess	protein deubiquitination	USP17L2 USP17L20 USP17L11 USP17L24 USP24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	5.06e-12	125	146	13	GO:0016579
GeneOntologyBiologicalProcess	protein modification by small protein removal	USP17L2 USP17L20 USP17L11 USP17L24 USP24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	3.10e-11	144	146	13	GO:0070646
GeneOntologyBiologicalProcess	post-translational protein modification	DCAF1 TRIM25 USP17L2 USP17L20 USP17L11 USP17L24 USP24 USP17L5 RNF213 RELA USP17L19 WNK1 TRIP12 USP17L18 FBXL7 USP17L17 USP17L6P N4BP1 USP17L22 USP17L15 USP17L13 PARP15	6.80e-06	1074	146	22	GO:0043687
GeneOntologyBiologicalProcess	protein modification by small protein conjugation or removal	DCAF1 TRIM25 USP17L2 USP17L20 USP17L11 USP17L24 USP24 USP17L5 RNF213 RELA USP17L19 WNK1 TRIP12 USP17L18 FBXL7 USP17L17 USP17L6P N4BP1 USP17L22 USP17L15 USP17L13	8.86e-06	1009	146	21	GO:0070647
GeneOntologyBiologicalProcess	positive regulation of glucokinase activity	RGPD4 RGPD1 RGPD3	2.83e-05	9	146	3	GO:0033133
GeneOntologyBiologicalProcess	positive regulation of hexokinase activity	RGPD4 RGPD1 RGPD3	4.02e-05	10	146	3	GO:1903301
GeneOntologyBiologicalProcess	chromatin organization	DCAF1 KDM5C ASH1L CHD1 RELA UBN2 TRIP12 JMJD1C ITGB3BP ZNF462 BPTF KMT2C RESF1 ZNF827 SCMH1 TET1 ATF7IP2 HR	6.48e-05	896	146	18	GO:0006325
GeneOntologyBiologicalProcess	regulation of glucokinase activity	RGPD4 RGPD1 RGPD3	9.43e-05	13	146	3	GO:0033131
GeneOntologyBiologicalProcess	regulation of hexokinase activity	RGPD4 RGPD1 RGPD3	1.19e-04	14	146	3	GO:1903299
GeneOntologyBiologicalProcess	negative regulation of microtubule depolymerization	MAP1A MAP1B MID1 NAV3	1.47e-04	38	146	4	GO:0007026
GeneOntologyBiologicalProcess	protein peptidyl-prolyl isomerization	RGPD4 RGPD1 RGPD3 NKTR	1.47e-04	38	146	4	GO:0000413
GeneOntologyBiologicalProcess	regulation of microtubule depolymerization	MAP1A MAP1B MID1 NAV3	2.19e-04	42	146	4	GO:0031114
GeneOntologyBiologicalProcess	protein-DNA complex organization	DCAF1 KDM5C ASH1L CHD1 RELA UBN2 TRIP12 JMJD1C ITGB3BP ZNF462 BPTF KMT2C RESF1 ZNF827 SCMH1 TET1 ATF7IP2 HR	2.51e-04	999	146	18	GO:0071824
GeneOntologyBiologicalProcess	chromatin remodeling	DCAF1 KDM5C ASH1L CHD1 TRIP12 JMJD1C ITGB3BP BPTF KMT2C RESF1 ZNF827 SCMH1 TET1 ATF7IP2 HR	2.52e-04	741	146	15	GO:0006338
GeneOntologyBiologicalProcess	positive regulation of MDA-5 signaling pathway	USP17L2 ANKRD17	2.96e-04	4	146	2	GO:1900245
GeneOntologyBiologicalProcess	NLS-bearing protein import into nucleus	RGPD4 RGPD1 RGPD3	3.63e-04	20	146	3	GO:0006607
GeneOntologyCellularComponent	cytoplasmic periphery of the nuclear pore complex	RGPD4 RGPD1 RGPD3	2.10e-05	8	153	3	GO:1990723
GeneOntologyCellularComponent	nuclear pore cytoplasmic filaments	RGPD4 RGPD1 RGPD3	4.44e-05	10	153	3	GO:0044614
GeneOntologyCellularComponent	annulate lamellae	RGPD4 RGPD1 RGPD3	1.32e-04	14	153	3	GO:0005642
GeneOntologyCellularComponent	nuclear pore nuclear basket	RGPD4 RGPD1 RGPD3	2.89e-04	18	153	3	GO:0044615
GeneOntologyCellularComponent	nuclear inclusion body	RGPD4 RGPD1 RGPD3	4.00e-04	20	153	3	GO:0042405
GeneOntologyCellularComponent	SUMO ligase complex	RGPD4 RGPD1 RGPD3	4.64e-04	21	153	3	GO:0106068
GeneOntologyCellularComponent	costamere	ANK2 CMYA5 DMD	5.35e-04	22	153	3	GO:0043034
GeneOntologyCellularComponent	super elongation complex	AFF3 AFF1	7.83e-04	6	153	2	GO:0032783
Domain	HABP4_PAI-RBP1	USP17L2 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13	6.78e-18	16	151	10	PF04774
Domain	HABP4_PAIRBP1-bd	USP17L2 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13	6.78e-18	16	151	10	IPR006861
Domain	USP_CS	USP17L2 USP17L20 USP17L11 USP17L24 USP24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13	4.90e-12	66	151	11	IPR018200
Domain	USP_1	USP17L2 USP17L20 USP17L11 USP17L24 USP24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13	9.60e-12	70	151	11	PS00972
Domain	UCH	USP17L2 USP17L20 USP17L11 USP17L24 USP24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13	1.13e-11	71	151	11	PF00443
Domain	USP_2	USP17L2 USP17L20 USP17L11 USP17L24 USP24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13	1.13e-11	71	151	11	PS00973
Domain	USP_3	USP17L2 USP17L20 USP17L11 USP17L24 USP24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13	1.32e-11	72	151	11	PS50235
Domain	USP_dom	USP17L2 USP17L20 USP17L11 USP17L24 USP24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13	1.32e-11	72	151	11	IPR028889
Domain	Peptidase_C19_UCH	USP17L2 USP17L20 USP17L11 USP17L24 USP24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13	1.32e-11	72	151	11	IPR001394
Domain	Rab_bind	RGPD4 RGPD1 RGPD3	1.77e-05	7	151	3	PF16704
Domain	GCC2_Rab_bind	RGPD4 RGPD1 RGPD3	1.77e-05	7	151	3	IPR032023
Domain	-	RGPD4 RGPD1 RGPD3	5.96e-05	10	151	3	1.10.220.60
Domain	Grip	RGPD4 RGPD1 RGPD3	8.15e-05	11	151	3	SM00755
Domain	GRIP	RGPD4 RGPD1 RGPD3	8.15e-05	11	151	3	PF01465
Domain	Ran_BP1	RGPD4 RGPD1 RGPD3	1.08e-04	12	151	3	PF00638
Domain	RANBD1	RGPD4 RGPD1 RGPD3	1.08e-04	12	151	3	PS50196
Domain	GRIP_dom	RGPD4 RGPD1 RGPD3	1.08e-04	12	151	3	IPR000237
Domain	GRIP	RGPD4 RGPD1 RGPD3	1.08e-04	12	151	3	PS50913
Domain	RanBD	RGPD4 RGPD1 RGPD3	1.40e-04	13	151	3	SM00160
Domain	Ran_bind_dom	RGPD4 RGPD1 RGPD3	1.40e-04	13	151	3	IPR000156
Domain	MAP1	MAP1A MAP1B	1.94e-04	3	151	2	IPR026074
Domain	-	CEP95 NAV3 NAV2 LIMCH1 DMD	2.74e-04	71	151	5	1.10.418.10
Domain	CH-domain	CEP95 NAV3 NAV2 LIMCH1 DMD	3.54e-04	75	151	5	IPR001715
Domain	TF_AF4/FMR2	AFF3 AFF1	3.85e-04	4	151	2	IPR007797
Domain	AF-4	AFF3 AFF1	3.85e-04	4	151	2	PF05110
Domain	JmjC	KDM5C JMJD1C HR	9.26e-04	24	151	3	PF02373
Domain	Znf_FYVE_PHD	KDM5C PLEKHF2 PCLO ASH1L BPTF KMT2C	1.25e-03	147	151	6	IPR011011
Domain	-	RGPD4 PLEKHF2 RGPD1 ARHGEF12 CDC42BPB RGS12 PLEKHG1 MTMR7 CCM2 RGPD3	1.32e-03	391	151	10	2.30.29.30
Domain	ZINC_FINGER_C2H2_2	ZNF438 ZNF567 TSHZ3 ZNF280C TRPS1 ZNF181 ZFP37 ZNF551 ZNF462 HIVEP3 ZNF608 ZNF827 ZNF197 SCAPER ZNF534	1.56e-03	775	151	15	PS50157
Domain	ZINC_FINGER_C2H2_1	ZNF438 ZNF567 TSHZ3 ZNF280C TRPS1 ZNF181 ZFP37 ZNF551 ZNF462 HIVEP3 ZNF608 ZNF827 ZNF197 SCAPER ZNF534	1.60e-03	777	151	15	PS00028
Pathway	REACTOME_RAS_PROCESSING	USP17L2 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	1.21e-14	45	101	11	MM15671
Pathway	REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES	USP17L2 USP17L20 USP17L11 USP24 USP17L5 USP17L19 USP17L18 USP17L17 PTRH2 USP17L6P CLSPN USP17L22 USP17L15 USP17L13	7.97e-11	191	101	14	MM15289
Pathway	REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES	USP17L2 USP17L20 USP17L11 USP17L24 USP24 USP17L5 USP17L19 USP17L18 USP17L17 PTRH2 CLSPN USP17L22 USP17L15 USP17L13	5.52e-10	221	101	14	M27578
Pathway	REACTOME_DEUBIQUITINATION	TRIM25 USP17L2 USP17L20 USP17L11 USP17L24 USP24 USP17L5 USP17L19 USP17L18 USP17L17 PTRH2 CLSPN USP17L22 USP17L15 USP17L13	3.22e-09	299	101	15	M27574
Pathway	REACTOME_DEUBIQUITINATION	USP17L2 USP17L20 USP17L11 USP24 USP17L5 USP17L19 USP17L18 USP17L17 PTRH2 USP17L6P CLSPN USP17L22 USP17L15 USP17L13	5.04e-09	262	101	14	MM15286
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	RGPD4 CASP8AP2 USP17L2 USP17L20 USP17L11 USP24 RGPD1 MUC16 USP17L5 RELA USP17L19 TGOLN2 USP17L18 FBXL7 USP17L17 SCMH1 RGPD3 MITF PTRH2 USP17L6P NR3C2 CLSPN USP17L22 USP17L15 USP17L13	1.12e-05	1389	101	25	MM15307
Pathway	REACTOME_MAPK_FAMILY_SIGNALING_CASCADES	USP17L2 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	1.69e-05	318	101	11	MM15278
Pathway	REACTOME_SUMOYLATION	RGPD4 CASP8AP2 RGPD1 RELA SCMH1 RGPD3 MITF NR3C2	2.83e-05	169	101	8	MM14919
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	CASP8AP2 TRIM25 USP17L2 ANK2 USP17L20 USP17L11 USP17L24 USP24 MUC16 USP17L5 RELA USP17L19 TGOLN2 USP17L18 FBXL7 USP17L17 SCMH1 MITF PTRH2 NR3C2 CLSPN USP17L22 USP17L15 USP17L13	9.00e-05	1475	101	24	M19806
Pathway	BIOCARTA_RANBP2_PATHWAY	RGPD4 RGPD1 RGPD3	2.69e-04	18	101	3	MM1549
Pubmed	DUB-1, a deubiquitinating enzyme with growth-suppressing activity.	USP17L2 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	3.26e-21	21	155	11	8622927
Pubmed	DUB-1A, a novel deubiquitinating enzyme subfamily member, is polyubiquitinated and cytokine-inducible in B-lymphocytes.	USP17L2 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	3.26e-21	21	155	11	14583620
Pubmed	DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes.	USP17L2 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	3.26e-21	21	155	11	11468161
Pubmed	The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor.	USP17L2 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	3.26e-21	21	155	11	8756639
Pubmed	Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines.	USP17L2 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	3.26e-21	21	155	11	12447969
Pubmed	DUB-1, a fate determinant of dynein heavy chain in B-lymphocytes, is regulated by the ubiquitin-proteasome pathway.	USP17L2 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	3.26e-21	21	155	11	18980247
Pubmed	JAK2 is required for induction of the murine DUB-1 gene.	USP17L2 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	6.49e-21	22	155	11	9154835
Pubmed	Cdc25A and Dub3 in a high-stakes balancing act.	USP17L2 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	1.30e-20	33	155	12	20228807
Pubmed	The DUB/USP17 deubiquitinating enzymes: a gene family within a tandemly repeated sequence, is also embedded within the copy number variable beta-defensin cluster.	USP17L2 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	2.00e-20	34	155	12	20403174
Pubmed	DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation.	USP17L2 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	2.00e-20	34	155	12	14699124
Pubmed	The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence.	USP17L2 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	2.00e-20	34	155	12	15780755
Pubmed	USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity.	USP17L2 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	2.00e-20	34	155	12	19188362
Pubmed	Unstable transmission of the RS447 human megasatellite tandem repetitive sequence that contains the USP17 deubiquitinating enzyme gene.	USP17L2 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	2.00e-20	34	155	12	11941478
Pubmed	Hyaluronan- and RNA-binding deubiquitinating enzymes of USP17 family members associated with cell viability.	USP17L2 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	2.00e-20	34	155	12	17109758
Pubmed	The deubiquitinating enzyme USP17 is highly expressed in tumor biopsies, is cell cycle regulated, and is required for G1-S progression.	USP17L2 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	2.00e-20	34	155	12	20388806
Pubmed	Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme.	USP17L2 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	2.00e-20	34	155	12	20715989
Pubmed	Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation.	USP17L2 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	2.00e-20	34	155	12	9806828
Pubmed	The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling.	USP17L2 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	2.00e-20	34	155	12	20368735
Pubmed	The RS447 human megasatellite tandem repetitive sequence encodes a novel deubiquitinating enzyme with a functional promoter.	USP17L2 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	2.00e-20	34	155	12	10936051
Pubmed	The deubiquitinating enzyme USP17 is essential for GTPase subcellular localization and cell motility.	USP17L2 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	2.00e-20	34	155	12	21448158
Pubmed	DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes.	USP17L2 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	2.28e-20	24	155	11	8995226
Pubmed	Cytokine-regulated protein degradation by the ubiquitination system.	USP17L2 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	3.04e-20	35	155	12	16611142
Pubmed	Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity.	USP17L2 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	3.04e-20	35	155	12	21239494
Pubmed	Interleukin 1 receptor signaling regulates DUBA expression and facilitates Toll-like receptor 9-driven antiinflammatory cytokine production.	USP17L2 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	4.06e-20	25	155	11	21115691
Pubmed	The deubiquitinating enzyme USP17 blocks N-Ras membrane trafficking and activation but leaves K-Ras unaffected.	USP17L2 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	4.54e-20	36	155	12	20147298
Pubmed	Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A.	USP17L2 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	6.70e-20	37	155	12	20228808
Pubmed	Decabromodiphenyl ethane affects embryonic development by interfering with nuclear F-actin in zygotes and leads to cognitive and social disorders in offspring mice.	USP17L2 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	7.00e-20	26	155	11	35816173
Pubmed	Minor Splicing Factors Zrsr1 and Zrsr2 Are Essential for Early Embryo Development and 2-Cell-Like Conversion.	USP17L2 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	3.10e-19	29	155	11	32527007
Pubmed	DUX is a non-essential synchronizer of zygotic genome activation.	USP17L2 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	3.09e-16	50	155	11	31806660
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	PHACTR2 MAP1B EXPH5 KIAA0232 PPFIA1 LMTK2 ITPRID2 WNK1 TRIP12 RGS12 FAM83B CEP350 PLEKHG1 RESF1 CEP95 SYDE2 TET1 NAV2 ANKRD17 HELZ NR3C2 TANC1 LIMCH1 KIF13A	8.74e-13	861	155	24	36931259
Pubmed	A human MAP kinase interactome.	CASP8AP2 MAP1A EXPH5 KIAA0232 RELA ITPRID2 WNK1 CDC42BPB CEP350 KMT2C CEP95 NAV3 NAV2 ANKRD17 HELZ NKTR DMD RBFOX2	7.76e-12	486	155	18	20936779
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	RGPD4 CASP8AP2 TSHZ3 PPFIA1 TRPS1 USP24 RGPD1 JMJD1C ZNF462 RESF1 ZNF608 TLE3 RGPD3 TET1 ATF7IP2 ANKRD17	7.41e-11	418	155	16	34709266
Pubmed	Interaction network of human early embryonic transcription factors.	TSHZ3 TRPS1 RGPD1 UBN2 ZNF462 BPTF KMT2C RESF1 ZNF608 TLE3 TET1 MITF SLX4	7.11e-09	351	155	13	38297188
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	CWF19L2 MAP1A MAP1B UBN2 JMJD1C DNTTIP2 ARID3B RESF1 DDX50 ZNF608 TLE3 RGPD3 MITF SLX4	1.41e-08	444	155	14	34795231
Pubmed	A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal.	RGPD4 RGPD1 ARID3B ZNF462 BPTF KMT2C RGPD3 TET1 RBFOX2	2.11e-08	146	155	9	23892456
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	CACNB2 MAP1B KIAA0232 AFF3 TRPS1 ASH1L RNF213 UBN2 CDC42BPB JMJD1C PCNX2 ZNF462 HIVEP3 BPTF KMT2C ZNF608 ZNF827 TLE3 KCNMA1 ANKRD17 AFF1 TANC1 LIMCH1 RBFOX2	4.99e-08	1489	155	24	28611215
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	CASP8AP2 BCLAF1 KDM5C ZNF280C LMTK2 KMT2C FBXL7 ZNF608 TET1 NAV2 ANKRD17 FLRT3 MAML2 FAM149B1	1.22e-07	529	155	14	14621295
Pubmed	Embryonic demise caused by targeted disruption of a cysteine protease Dub-2.	USP17L2 USP17L15 USP17L13	3.46e-07	4	155	3	22984479
Pubmed	Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder.	BCLAF1 ASH1L UBN2 CDC42BPB	3.67e-07	14	155	4	28263302
Pubmed	USP7 represses lineage differentiation genes in mouse embryonic stem cells by both catalytic and noncatalytic activities.	USP17L2 USP17L20 USP17L11 ZNF280C TRPS1 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P NAV2 ANKRD45 USP17L22 USP17L15 USP17L13	3.90e-07	674	155	15	37196079
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	CACNB2 PPFIA1 ASH1L LMTK2 FAM76B ADGRE2 UBN2 WNK1 TRIP12 ZFP37 DNTTIP2 KMT2C RESF1 DDX50 TET1 ANKRD17 AFF1 KIF13A SLX4	4.05e-07	1084	155	19	11544199
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	RGPD4 CYLC1 PHACTR2 ANK2 MAP1B BCLAF1 PPP1R12B PPFIA1 PCLO ASH1L RGPD1 CAGE1 TRIP12 DNTTIP2 BPTF DDX50 ZNF608 RGPD3 NAV2 LIMCH1 DMD CCDC158	4.85e-07	1442	155	22	35575683
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	TSHZ3 TRIM25 MAP1A SCYL1 ITPRID2 WNK1 TRIP12 ATF7IP2 MITF AFF1 MAML2 CLSPN	5.79e-07	430	155	12	35044719
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	CWF19L2 AFF3 CHD1 REV3L UBN2 ARID3B ZNF462 RESF1 SLX4	7.50e-07	222	155	9	37071664
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	CASP8AP2 KIAA0232 WNK1 CDC42BPB ZNF462 KMT2C FBXL7 ZNF608 NAV2	8.39e-07	225	155	9	12168954
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	RGPD4 CACNB2 ANK2 BCLAF1 PPFIA1 RGPD1 ARHGEF12 GRIN2A UBN2 CDC42BPB ZNF462 FRY SPHKAP RGPD3 KCNMA1 ANKRD17 LIMCH1	1.57e-06	963	155	17	28671696
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	TRPS1 JMJD1C ARID3B BPTF ZNF608 TLE3	2.02e-06	83	155	6	28794006
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	BCLAF1 PPFIA1 SCYL1 MUC16 RNF213 RELA AGPS TRIP12 CDC42BPB FAM83B ARID3B CEP350 DDX50 SYDE2 CLSPN	2.27e-06	777	155	15	35844135
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	EXPH5 RNF213 UBN2 WNK1 CDC42BPB JMJD1C CEP350 ZNF462 HIVEP3 SCAPER N4BP1 SLX4	2.40e-06	493	155	12	15368895
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	CASP8AP2 CWF19L2 MAP1A KDM5C ITPRID2 UBN2 WNK1 FAM83B RESF1 HELZ TANC1 CLSPN SLX4	2.59e-06	588	155	13	38580884
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	DCAF1 MAP1A KDM5C PPFIA1 TRPS1 ASH1L RNF213 REV3L DNTTIP2 BPTF RESF1 ZNF608 ZNF827 SCAPER ANKRD17 HELZ TANC1 CLSPN	2.70e-06	1116	155	18	31753913
Pubmed	Tagging genes with cassette-exchange sites.	ARHGEF12 TRIP12 ZNF462 BPTF KMT2C RESF1 TET1 NAV2 HELZ TANC1	2.87e-06	335	155	10	15741177
Pubmed	Interconversion of red opsin isoforms by the cyclophilin-related chaperone protein Ran-binding protein 2.	RGPD4 RGPD1 RGPD3	3.00e-06	7	155	3	9037092
Pubmed	Complex genomic rearrangements lead to novel primate gene function.	RGPD4 RGPD1 RGPD3	3.00e-06	7	155	3	15710750
Pubmed	Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene.	RGPD4 RGPD1 RGPD3	3.00e-06	7	155	3	11353387
Pubmed	Microglial activation in an amyotrophic lateral sclerosis-like model caused by Ranbp2 loss and nucleocytoplasmic transport impairment in retinal ganglion neurons.	RGPD4 RGPD1 RGPD3	3.00e-06	7	155	3	30944974
Pubmed	Nucleoporin Nup358 drives the differentiation of myeloid-biased multipotent progenitors by modulating HDAC3 nuclear translocation.	RGPD4 RGPD1 RGPD3	3.00e-06	7	155	3	38838144
Pubmed	Retina-specifically expressed novel subtypes of bovine cyclophilin.	RGPD4 RGPD1 RGPD3	3.00e-06	7	155	3	7559465
Pubmed	Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate.	RGPD4 RGPD1 RGPD3	3.00e-06	7	155	3	17372272
Pubmed	Proteostatic Remodeling of Small Heat Shock Chaperones─Crystallins by Ran-Binding Protein 2─and the Peptidyl-Prolyl cis-trans Isomerase and Chaperone Activities of Its Cyclophilin Domain.	RGPD4 RGPD1 RGPD3	3.00e-06	7	155	3	38657106
Pubmed	Nup358, a nucleoporin, functions as a key determinant of the nuclear pore complex structure remodeling during skeletal myogenesis.	RGPD4 RGPD1 RGPD3	3.00e-06	7	155	3	21205196
Pubmed	Haploinsufficiency of RanBP2 is neuroprotective against light-elicited and age-dependent degeneration of photoreceptor neurons.	RGPD4 RGPD1 RGPD3	3.00e-06	7	155	3	18949001
Pubmed	Selective impairment of a subset of Ran-GTP-binding domains of ran-binding protein 2 (Ranbp2) suffices to recapitulate the degeneration of the retinal pigment epithelium (RPE) triggered by Ranbp2 ablation.	RGPD4 RGPD1 RGPD3	3.00e-06	7	155	3	25187515
Pubmed	Localization of the Ran-GTP binding protein RanBP2 at the cytoplasmic side of the nuclear pore complex.	RGPD4 RGPD1 RGPD3	3.00e-06	7	155	3	8603673
Pubmed	Uncoupling phototoxicity-elicited neural dysmorphology and death by insidious function and selective impairment of Ran-binding protein 2 (Ranbp2).	RGPD4 RGPD1 RGPD3	3.00e-06	7	155	3	26632511
Pubmed	Differential loss of prolyl isomerase or chaperone activity of Ran-binding protein 2 (Ranbp2) unveils distinct physiological roles of its cyclophilin domain in proteostasis.	RGPD4 RGPD1 RGPD3	3.00e-06	7	155	3	24403063
Pubmed	Distinct and atypical intrinsic and extrinsic cell death pathways between photoreceptor cell types upon specific ablation of Ranbp2 in cone photoreceptors.	RGPD4 RGPD1 RGPD3	3.00e-06	7	155	3	23818861
Pubmed	Kinesin-1 and mitochondrial motility control by discrimination of structurally equivalent but distinct subdomains in Ran-GTP-binding domains of Ran-binding protein 2.	RGPD4 RGPD1 RGPD3	3.00e-06	7	155	3	23536549
Pubmed	Identification of RanBP2- and kinesin-mediated transport pathways with restricted neuronal and subcellular localization.	RGPD4 RGPD1 RGPD3	3.00e-06	7	155	3	12191015
Pubmed	Ranbp2 haploinsufficiency mediates distinct cellular and biochemical phenotypes in brain and retinal dopaminergic and glia cells elicited by the Parkinsonian neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).	RGPD4 RGPD1 RGPD3	3.00e-06	7	155	3	22821000
Pubmed	Neuroprotection resulting from insufficiency of RANBP2 is associated with the modulation of protein and lipid homeostasis of functionally diverse but linked pathways in response to oxidative stress.	RGPD4 RGPD1 RGPD3	3.00e-06	7	155	3	20682751
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	TRIM25 PPP1R12B PPFIA1 TRPS1 ARHGEF12 FAM76B CHD1 RELA ITPRID2 UBN2 CDC42BPB FAM83B KMT2C DDX50 RGPD3 PTRH2 ANKRD17 HELZ TANC1 LIMCH1 HEATR5B	3.39e-06	1497	155	21	31527615
Pubmed	BCOR modulates transcriptional activity of a subset of glucocorticoid receptor target genes involved in cell growth and mobility.	JMJD1C ARID3B ZNF608 TLE3	3.76e-06	24	155	4	33722704
Pubmed	The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity.	RGPD4 RGPD1 RGPD3	4.78e-06	8	155	3	21670213
Pubmed	Critical role of RanBP2-mediated SUMOylation of Small Heterodimer Partner in maintaining bile acid homeostasis.	RGPD4 RGPD1 RGPD3	4.78e-06	8	155	3	27412403
Pubmed	Mice lacking Ran binding protein 1 are viable and show male infertility.	RGPD4 RGPD1 RGPD3	4.78e-06	8	155	3	21310149
Pubmed	The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2.	RGPD4 RGPD1 RGPD3	4.78e-06	8	155	3	22262462
Pubmed	Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes.	RGPD4 RGPD1 RGPD3	4.78e-06	8	155	3	28745977
Pubmed	Defects in Synaptic Plasticity, Reduced NMDA-Receptor Transport, and Instability of Postsynaptic Density Proteins in Mice Lacking Microtubule-Associated Protein 1A.	MAP1A MAP1B GRIN2A	4.78e-06	8	155	3	26609151
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	PPP1R12B PPFIA1 ZNF280C TRPS1 LMTK2 RNF213 RELA ITPRID2 CDC42BPB CEP350 MTMR7 DDX50 TLE3 KCNMA1 HELZ TANC1 DMD	4.89e-06	1049	155	17	27880917
Pubmed	NANOG-dependent function of TET1 and TET2 in establishment of pluripotency.	JMJD1C ARID3B BPTF TET1	6.15e-06	27	155	4	23395962
Pubmed	Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha.	RGPD4 RGPD1 RGPD3	7.15e-06	9	155	3	18394993
Pubmed	Loss of Ranbp2 in motoneurons causes disruption of nucleocytoplasmic and chemokine signaling, proteostasis of hnRNPH3 and Mmp28, and development of amyotrophic lateral sclerosis-like syndromes.	RGPD4 RGPD1 RGPD3	7.15e-06	9	155	3	28100513
Pubmed	Association of the kinesin-binding domain of RanBP2 to KIF5B and KIF5C determines mitochondria localization and function.	RGPD4 RGPD1 RGPD3	7.15e-06	9	155	3	17887960
Pubmed	The docking of kinesins, KIF5B and KIF5C, to Ran-binding protein 2 (RanBP2) is mediated via a novel RanBP2 domain.	RGPD4 RGPD1 RGPD3	7.15e-06	9	155	3	11553612
Pubmed	The zinc finger cluster domain of RanBP2 is a specific docking site for the nuclear export factor, exportin-1.	RGPD4 RGPD1 RGPD3	7.15e-06	9	155	3	10601307
Pubmed	The cyclophilin-like domain mediates the association of Ran-binding protein 2 with subunits of the 19 S regulatory complex of the proteasome.	RGPD4 RGPD1 RGPD3	7.15e-06	9	155	3	9733766
Pubmed	Impairments in age-dependent ubiquitin proteostasis and structural integrity of selective neurons by uncoupling Ran GTPase from the Ran-binding domain 3 of Ranbp2 and identification of novel mitochondrial isoforms of ubiquitin-conjugating enzyme E2I (ubc9) and Ranbp2.	RGPD4 RGPD1 RGPD3	7.15e-06	9	155	3	28877029
Pubmed	Comprehensive identification of phosphorylation sites in postsynaptic density preparations.	RGPD4 MAP1A MAP1B BCLAF1 PCLO RGPD1 GRIN2A RGPD3	9.98e-06	231	155	8	16452087
Pubmed	The RanBP2/RanGAP1*SUMO1/Ubc9 SUMO E3 ligase is a disassembly machine for Crm1-dependent nuclear export complexes.	RGPD4 RGPD1 RGPD3	1.02e-05	10	155	3	27160050
Pubmed	Parkin ubiquitinates and promotes the degradation of RanBP2.	RGPD4 RGPD1 RGPD3	1.02e-05	10	155	3	16332688
Pubmed	Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin.	RGPD4 RGPD1 RGPD3	1.02e-05	10	155	3	8857542
Pubmed	High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency.	USP17L2 USP17L6P USP17L15	1.02e-05	10	155	3	24207026
Pubmed	Ran-dependent docking of importin-beta to RanBP2/Nup358 filaments is essential for protein import and cell viability.	RGPD4 RGPD1 RGPD3	1.02e-05	10	155	3	21859863
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	BCLAF1 KDM5C USP24 FAM76B ITPRID2 TRIP12 ZNF551 BPTF TLE3 ANKRD17 AFF1 HELZ LIMCH1 PRG4	1.05e-05	774	155	14	15302935
Pubmed	RanBP2 modulates Cox11 and hexokinase I activities and haploinsufficiency of RanBP2 causes deficits in glucose metabolism.	RGPD4 RGPD1 RGPD3	1.40e-05	11	155	3	17069463
Pubmed	An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age.	RGPD4 RGPD1 RGPD3	1.40e-05	11	155	3	35771867
Pubmed	T-cell receptor (TCR) signaling promotes the assembly of RanBP2/RanGAP1-SUMO1/Ubc9 nuclear pore subcomplex via PKC-θ-mediated phosphorylation of RanGAP1.	RGPD4 RGPD1 RGPD3	1.40e-05	11	155	3	34110283
Pubmed	Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.	DCAF1 KDM5C SCYL1 ITPRID2 JMJD1C CEP350 ANKRD17 CLSPN	1.40e-05	242	155	8	34011540
Pubmed	SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors.	MAP1B KDM5C RNF213 CHD1 TRIP12 BPTF DDX50 HELZ	1.77e-05	250	155	8	33536335
Interaction	YWHAG interactions	PHACTR2 BCLAF1 EXPH5 KIAA0232 PPFIA1 USP24 LMTK2 ITPRID2 WNK1 TRIP12 RGS12 DNTTIP2 TGOLN2 FAM83B CEP350 PLEKHG1 CEP95 SYDE2 TET1 MITF KCNMA1 NAV2 ANKRD17 HELZ NKTR TANC1 KIF13A	4.90e-07	1248	150	27	int:YWHAG
Interaction	SFN interactions	TRIM25 MAP1A MAP1B EXPH5 KIAA0232 PLEKHF2 PPFIA1 LMTK2 ITPRID2 WNK1 TRIP12 RGS12 FAM83B CEP350 CEP95 NAV2 ANKRD17 TANC1 KIF13A	9.74e-07	692	150	19	int:SFN
Interaction	NUP43 interactions	DCAF1 CASP8AP2 BCLAF1 KDM5C ZNF280C ASH1L CHD1 ITPRID2 UBN2 TRIP12 JMJD1C DNTTIP2 ZNF462 BPTF RESF1 ZNF608 NKTR SLX4	9.77e-07	625	150	18	int:NUP43
Interaction	YWHAH interactions	PHACTR2 EXPH5 KIAA0232 PPFIA1 LMTK2 ITPRID2 WNK1 TRIP12 RGS12 FAM83B CEP350 PLEKHG1 RESF1 CEP95 SYDE2 TET1 MITF KCNMA1 NAV2 ANKRD17 NR3C2 NKTR TANC1 LIMCH1	2.07e-06	1102	150	24	int:YWHAH
Interaction	SOX7 interactions	TRPS1 JMJD1C ARID3B KMT2C RESF1 ZNF608 TLE3	2.62e-06	82	150	7	int:SOX7
Interaction	EGR2 interactions	TRPS1 UBN2 ZNF462 KMT2C RESF1 ZNF608 TLE3 TET1 MITF	5.50e-06	171	150	9	int:EGR2
Interaction	TEAD1 interactions	TSHZ3 TRIM25 TRPS1 ARID3B ZNF462 BPTF KMT2C ZNF608 TLE3	6.96e-06	176	150	9	int:TEAD1
Interaction	SMG7 interactions	TSHZ3 TRIM25 TRPS1 AGPS JMJD1C ZNF608 TLE3 TET1 ANKRD17 HELZ CLSPN	2.78e-05	319	150	11	int:SMG7
Interaction	ERG interactions	TRIM25 TRPS1 TRIP12 KMT2C RESF1 ZNF608 TLE3 MITF SLX4	4.55e-05	223	150	9	int:ERG
Interaction	KLF3 interactions	TSHZ3 TRIM25 TRPS1 UBN2 JMJD1C ARID3B BPTF ZNF608 TLE3	5.41e-05	228	150	9	int:KLF3
Interaction	NANOG interactions	BCLAF1 MUC16 RELA TRIP12 JMJD1C DNTTIP2 ARID3B ZNF462 BPTF KMT2C RESF1 TET1 RBFOX2	6.52e-05	481	150	13	int:NANOG
Interaction	KDM1A interactions	CASP8AP2 TSHZ3 TRIM25 PPFIA1 ZNF280C TRPS1 USP24 RELA CAGE1 JMJD1C ITGB3BP CEP350 ZNF462 RESF1 ZNF608 TLE3 TET1 ATF7IP2 ANKRD17	7.39e-05	941	150	19	int:KDM1A
Interaction	SOX9 interactions	TRPS1 RGPD1 UBN2 ARID3B KMT2C TLE3	8.71e-05	97	150	6	int:SOX9
Interaction	HNF1B interactions	BCLAF1 TRPS1 UBN2 ARID3B BPTF KMT2C ZNF608 TLE3	9.05e-05	190	150	8	int:HNF1B
Interaction	PAX6 interactions	TSHZ3 TRPS1 UBN2 ARID3B ZNF462 BPTF KMT2C ZNF608 TLE3 MID1 MITF	9.57e-05	366	150	11	int:PAX6
Interaction	KIF20A interactions	RGPD4 ZNF438 ANK2 BCLAF1 PCLO CHD1 ITPRID2 CDC42BPB RGS12 FAM83B PCNX2 ZNF462 DDX50 RGPD3 NAV3 NAV2 AFF1 HELZ KIF13A RBFOX2	1.07e-04	1052	150	20	int:KIF20A
Interaction	VPS33B interactions	PPFIA1 ARHGEF12 ITPRID2 TGOLN2 CEP350 PLEKHG1 MTMR7 N4BP1	1.25e-04	199	150	8	int:VPS33B
Interaction	H2BC9 interactions	CYLC1 CASP8AP2 PHACTR2 MAP1B ABCA13 PCLO ASH1L CDC42BPB ADGRG4 CEP350 BPTF ATF7IP2	1.31e-04	446	150	12	int:H2BC9
Interaction	VSX1 interactions	TSHZ3 TRPS1 ARID3B ZNF608 TLE3	1.32e-04	66	150	5	int:VSX1
Interaction	SOX2 interactions	DCAF1 TSHZ3 MAP1A MAP1B BCLAF1 TRPS1 USP24 ITPRID2 UBN2 TRIP12 JMJD1C ARID3B ZNF462 BPTF KMT2C DDX50 ZNF608 TLE3 MITF NAV3 NAV2 ANKRD17 HELZ RBFOX2	1.33e-04	1422	150	24	int:SOX2
Cytoband	4p16.1	USP17L20 USP17L11 KIAA0232 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	5.99e-17	79	155	12	4p16.1
Cytoband	Ensembl 112 genes in cytogenetic band chr4p16	USP17L20 USP17L11 KIAA0232 USP17L24 USP17L5 USP17L19 RGS12 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	8.65e-13	222	155	13	chr4p16
Cytoband	11q22.3	CWF19L2 EXPH5 ELMOD1	4.52e-04	44	155	3	11q22.3
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF438 ZNF567 TSHZ3 TRPS1 ZNF181 ZFP37 ZNF551 ZNF462 HIVEP3 ZNF608 ZNF827 ZNF197 SCAPER ZNF534	1.73e-05	718	93	14	28
GeneFamily	AF4/FMR2 family\|Super elongation complex	AFF3 AFF1	1.56e-04	4	93	2	1145
GeneFamily	Zinc fingers MYND-type\|A-kinase anchoring proteins	CMYA5 SPHKAP AKAP10	4.37e-04	29	93	3	396
GeneFamily	AF4/FMR2 family\|Super elongation complex	AFF3 AFF1	9.20e-04	9	93	2	1280
GeneFamily	PHD finger proteins	KDM5C ASH1L BPTF KMT2C	1.20e-03	90	93	4	88
GeneFamily	Ankyrin repeat domain containing	ANK2 PPP1R12B ANKRD34B ANKRD17 TANC1 ANKRD45	1.56e-03	242	93	6	403
GeneFamily	AT-rich interaction domain containing	KDM5C ARID3B	2.63e-03	15	93	2	418
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	RGPD4 RGPD1 RGPD3 TANC1	2.94e-03	115	93	4	769
Coexpression	MADAN_DPPA4_TARGETS	USP17L2 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 PLEKHG1 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	1.07e-13	86	153	12	MM1312
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN	USP17L2 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	5.90e-11	112	153	11	MM1095
Coexpression	GERY_CEBP_TARGETS	USP17L2 USP17L20 USP17L11 USP17L5 USP17L19 TGOLN2 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	1.86e-10	160	153	12	MM1155
Coexpression	LAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE	WNK1 LRP1B KMT2C SCMH1 MID1 MITF SCAPER NR3C2 LIMCH1 MAML2	6.90e-08	171	153	10	M39234
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	MAP1B PPFIA1 USP24 CHD1 REV3L TRIP12 CEP350 BPTF FBXL7 MID1 ANKRD17 AFF1 HELZ LIMCH1 RBFOX2	1.06e-07	466	153	15	M13522
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	MAP1B PPFIA1 USP24 CHD1 REV3L TRIP12 CEP350 BPTF FBXL7 MID1 MITF NAV3 ANKRD17 AFF1 HELZ AKAP10 N4BP1 DMD RBFOX2	6.48e-07	856	153	19	M4500
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP	DCAF1 USP17L2 USP17L20 USP17L11 USP17L5 USP17L19 TGOLN2 USP17L18 USP17L17 SCMH1 GKAP1 USP17L6P ANKRD17 USP17L22 USP17L15 USP17L13	1.32e-06	647	153	16	MM981
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE	CWF19L2 BCLAF1 AFF3 FAM76B CHD1 DNTTIP2 ITGB3BP CEP95 ATF7IP2 GKAP1 NKTR MAML2	1.59e-06	363	153	12	M41103
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	EXPH5 KIAA0232 USP24 CHD1 REV3L CEP350 BPTF NAV3 AFF1 HELZ N4BP1	1.63e-06	300	153	11	M8702
Coexpression	GSE7852_LN_VS_THYMUS_TREG_UP	BCLAF1 KIAA0232 ARHGEF12 MTMR7 NR3C2 TANC1 DMD KIF13A PRG4	2.83e-06	200	153	9	M5737
Coexpression	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN	ZNF438 CACNB2 ANK2 EXPH5 PPP1R12B OR8K3 CCDC7 ADGB ZNF462 KMT2C LPCAT2 TET1 GKAP1 NAV2 LIMCH1 DMD MUCL3 CA1	3.67e-06	873	153	18	M16009
Coexpression	LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE	USP24 WNK1 LRP1B MITF SCAPER NAV2 NR3C2 LIMCH1 MAML2	3.90e-06	208	153	9	M39233
Coexpression	AIZARANI_LIVER_C9_LSECS_1	PHACTR2 MAP1B CDC42BPB JMJD1C ZNF462 PLEKHG1 MID1 AFF1 TANC1 LIMCH1	1.27e-05	304	153	10	M39113
Coexpression	MARSON_BOUND_BY_FOXP3_STIMULATED	DCAF1 USP17L2 USP17L20 USP17L11 KDM5C ASH1L ARHGEF12 USP17L5 CHD1 USP17L19 CFAP43 TGOLN2 USP17L18 USP17L17 TLE3 USP17L6P USP17L22 USP17L15 USP17L13	1.66e-05	1072	153	19	MM1031
Coexpression	ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP	CACNB2 ANK2 ABCA13 MITF LIMCH1 MAML2 CA1	1.80e-05	139	153	7	M6754
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	CASP8AP2 CWF19L2 BCLAF1 PPFIA1 CHD1 REV3L ITGB3BP CEP350 BPTF RESF1 MID1 MITF GKAP1 NKTR	3.23e-05	656	153	14	M18979
Coexpression	LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES	CACNB2 PPP1R12B AFF3 FRY FBXL7 DMD KIF13A	3.64e-05	155	153	7	M39246
Coexpression	LAKE_ADULT_KIDNEY_C2_PODOCYTES	CACNB2 EXPH5 ARHGEF12 CMYA5 FRY FBXL7 TANC1 KIF13A	3.64e-05	212	153	8	M39221
Coexpression	AIZARANI_LIVER_C20_LSECS_3	MAP1B CDC42BPB JMJD1C DNTTIP2 ZNF462 PLEKHG1 MID1 TANC1 LIMCH1	6.21e-05	295	153	9	M39121
Coexpression	BROWNE_HCMV_INFECTION_18HR_UP	NPY1R PPFIA1 ZFP37 TLE3 MITF HELZ AKAP10	7.03e-05	172	153	7	M5388
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	PPP1R12B USP24 WNK1 CEP350 BPTF KMT2C PRR14L	9.35e-05	180	153	7	M8239
Coexpression	LAKE_ADULT_KIDNEY_C6_PROXIMAL_TUBULE_EPITHELIAL_CELLS_FIBRINOGEN_POS_S3	TRPS1 ASH1L RNF213 CHD1 ZNF462 FBXL7 MAML2	9.68e-05	181	153	7	M39225
Coexpression	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP	DCAF1 USP17L2 USP17L20 USP17L11 OSER1 USP17L5 USP17L19 TGOLN2 USP17L18 USP17L17 SCMH1 MITF GKAP1 USP17L6P ANKRD17 USP17L22 USP17L15 USP17L13 HR	1.01e-04	1226	153	19	MM979
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE	RGPD4 CWF19L2 PHACTR2 BCLAF1 AFF3 RGPD1 CHD1 CEP95 RGPD3 GKAP1 NKTR	1.12e-04	474	153	11	M40991
Coexpression	LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES	ARHGEF12 JMJD1C HIVEP3 FBXL7 NKTR LIMCH1	1.57e-04	137	153	6	M39241
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	BCLAF1 TRPS1 ASH1L USP24 RNF213 CHD1 REV3L WNK1 TRIP12 JMJD1C DNTTIP2 TGOLN2 CEP350 PCNX2 HIVEP3 BPTF KMT2C RESF1 HELZ AKAP10 N4BP1	1.63e-04	1492	153	21	M40023
Coexpression	TIEN_INTESTINE_PROBIOTICS_2HR_DN	PPFIA1 JMJD1C RESF1 N4BP1 FLRT3	1.78e-04	89	153	5	M8916
Coexpression	GSE28737_WT_VS_BCL6_HET_FOLLICULAR_BCELL_UP	EXPH5 ADGB LRGUK NWD2 DDX50 KCNMA1 MAML2	1.80e-04	200	153	7	M9391
Coexpression	GSE20715_0H_VS_6H_OZONE_TLR4_KO_LUNG_DN	ZNF280C USP24 CHD1 ITPRID2 CEP95 GKAP1 AFF1	1.80e-04	200	153	7	M4373
Coexpression	LAKE_ADULT_KIDNEY_C16_COLLECTING_SYSTEM_PRINCIPAL_CELLS_CORTEX	TRPS1 REV3L SCMH1 AFF1 NR3C2 LIMCH1	1.84e-04	141	153	6	M39235
Coexpression	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN	MAP1B BCLAF1 PPFIA1 CAGE1 AGPS S1PR3 TGOLN2 SPHKAP AKAP10 FLRT3 RBFOX2	2.46e-04	519	153	11	M3395
Coexpression	FOSTER_TOLERANT_MACROPHAGE_DN	RGPD4 PLEKHF2 RGPD1 CHD1 MTMR7 TLE3 RGPD3 AFF1 N4BP1 TANC1	2.49e-04	435	153	10	MM1221
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HNBGABA	NPY1R ANK2 MAP1B PCLO REV3L UBN2 LRP1B ZNF462 FRY SCAPER KCNMA1 CA1 RBFOX2	2.56e-04	703	153	13	M39070
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000	BCLAF1 KDM5C AFF3 TRPS1 ASH1L JMJD1C ZFP37 ZNF462 HIVEP3 KMT2C RESF1 SCMH1 TLE3 TET1 MID1 NAV2 NKTR RBFOX2	4.57e-06	801	138	18	gudmap_developingGonad_e14.5_ epididymis_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3	DCAF1 CASP8AP2 CWF19L2 CACNB2 NPY1R ANK2 BCLAF1 TRPS1 CHD1 REV3L UBN2 DNTTIP2 ARID3B ITGB3BP CEP350 ZNF462 BPTF TET1 MID1 FAM149B1 DMD ANKRD45 CLSPN	6.16e-06	1257	138	23	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500	DCAF1 CASP8AP2 CWF19L2 CACNB2 NPY1R ANK2 MAP1B BCLAF1 TRPS1 CHD1 REV3L UBN2 DNTTIP2 ARID3B ITGB3BP CEP350 ZNF462 BPTF TET1 MID1 FAM149B1 DMD ANKRD45 CLSPN	2.22e-05	1459	138	24	facebase_RNAseq_e10.5_Emin_LatNas_2500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000	ANK2 MAP1B KDM5C TRPS1 CHD1 REV3L WNK1 S1PR3 CEP350 ZNF462 TLE3 SCAPER KCNMA1 AKAP10 FLRT3 KIF13A RBFOX2	2.35e-05	818	138	17	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000	MAP1B KDM5C TRPS1 CHD1 REV3L WNK1 CEP350 SCAPER AKAP10 KIF13A RBFOX2	4.44e-05	385	138	11	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1	CACNB2 PPFIA1 ASH1L ARHGEF12 REV3L ZFP37 DDX50 CEP95 TET1 N4BP1 PRR14L NKTR FAM149B1 CLSPN HEATR5B SLX4	4.85e-05	780	138	16	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000	BCLAF1 KDM5C AFF3 TRPS1 ASH1L JMJD1C ZNF462 KMT2C RESF1 SCMH1 TLE3 TET1 MID1 NAV2 NKTR RBFOX2	5.63e-05	790	138	16	gudmap_developingGonad_e16.5_epididymis_1000
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000	KDM5C ASH1L JMJD1C ZFP37 KMT2C SCMH1 MID1 NAV2 NKTR	8.04e-05	275	138	9	gudmap_developingGonad_e14.5_ epididymis_1000_k3
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500	TRPS1 ASH1L SCMH1 TET1 MID1 NAV2 NKTR	9.27e-05	162	138	7	gudmap_developingGonad_e16.5_epididymis_500_k2
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000	KDM5C TRPS1 ASH1L JMJD1C TLE3 TET1 MID1 NAV2 NKTR	1.03e-04	284	138	9	gudmap_developingGonad_e16.5_epididymis_1000_k2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5	CASP8AP2 CWF19L2 MAP1B BCLAF1 CHD1 GKAP1 DMD CLSPN	1.41e-04	232	138	8	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5
CoexpressionAtlas	DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_1000	CASP8AP2 TSHZ3 MAP1B PPP1R12B TRPS1 CHD1 AGPS REV3L TRIP12 S1PR3 ZNF551 SCMH1 KCNMA1 FLRT3 RBFOX2	1.54e-04	772	138	15	gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4	DCAF1 CASP8AP2 CWF19L2 CACNB2 ANK2 MAP1A MAP1B BCLAF1 CHD1 REV3L ZFP37 ZNF462 BPTF MTMR7 CEP95 TLE3 GKAP1 FLRT3 DMD ANKRD45 CLSPN	2.07e-04	1370	138	21	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000	CASP8AP2 ZNF567 CWF19L2 ANK2 MAP1A MAP1B BCLAF1 PCLO TRPS1 CHD1 DNTTIP2 CEP350 MID1 GKAP1 SCAPER DMD CLSPN	2.21e-04	983	138	17	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000	TRIM25 PCLO TRPS1 ASH1L ARHGEF12 REV3L ZFP37 DDX50 MID1 N4BP1 TANC1 LIMCH1 ANKRD45 CLSPN HEATR5B KIF13A SLX4	2.27e-04	985	138	17	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000	CWF19L2 BCLAF1 TRPS1 ASH1L RNF213 JMJD1C ZFP37 RESF1 SCMH1 SPHKAP TET1 MID1 NAV2 ANKRD17 N4BP1	2.38e-04	804	138	15	gudmap_developingGonad_e12.5_ovary_1000
CoexpressionAtlas	DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_500	TSHZ3 MAP1B PPP1R12B TRPS1 CHD1 REV3L ZNF551 SCMH1 KCNMA1 RBFOX2	2.54e-04	393	138	10	gudmap_developingKidney_e15.5_Ureteral Smooth Musc_500
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_1000	CACNB2 AFF3 RNF213 REV3L RESF1 SCMH1 NAV2	2.56e-04	191	138	7	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_1000
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000	MAP1B BCLAF1 ASH1L JMJD1C ZFP37 ZNF462 RESF1 SCMH1 TLE3 SPHKAP TET1 N4BP1 NKTR FLRT3 RBFOX2	2.75e-04	815	138	15	gudmap_developingGonad_e11.5_ovary + mesonephros_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#1_top-relative-expression-ranked_100	MAP1B REV3L RBFOX2	2.82e-04	20	138	3	gudmap_developingLowerUrinaryTract_e14.5_ urethra_100_k1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2	CASP8AP2 CWF19L2 MAP1B PCLO CHD1 DNTTIP2 CEP350 GKAP1 DMD	3.01e-04	328	138	9	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2
CoexpressionAtlas	dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_1000	CACNB2 MAP1A AFF3 TRPS1 RNF213 REV3L ZFP37	3.29e-04	199	138	7	gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_1000
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500	BCLAF1 AFF3 TRPS1 ASH1L RESF1 SCMH1 TET1 MID1 NAV2 NKTR	3.29e-04	406	138	10	gudmap_developingGonad_e16.5_epididymis_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	CASP8AP2 CWF19L2 CACNB2 MAP1B PPFIA1 PCLO ASH1L CHD1 GKAP1 PRR14L NKTR FAM149B1 DMD CLSPN SLX4	3.38e-04	831	138	15	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5
CoexpressionAtlas	alpha beta T cells, T.8Nve.PP, TCRb+ CD8+ CD44low CD62L high, Peyer's Patch, avg-1	USP24 REV3L WNK1 CEP350 KMT2C ZNF827 TET1 TANC1 MAML2	3.59e-04	336	138	9	GSM538413_500
CoexpressionAtlas	DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#4_top-relative-expression-ranked_500	CHD1 REV3L ZNF551 SCMH1 RBFOX2	3.72e-04	94	138	5	gudmap_developingKidney_e15.5_Ureteral Smooth Musc_500_k4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500	PCLO TRPS1 ARHGEF12 REV3L DDX50 MID1 N4BP1 TANC1 LIMCH1 CLSPN HEATR5B	3.78e-04	492	138	11	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000	MAP1B TRPS1 REV3L CEP350 SCMH1 NAV3 RBFOX2	4.42e-04	209	138	7	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k1
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000	TRPS1 ASH1L JMJD1C ZFP37 SCMH1 TET1 MID1 NAV2	4.66e-04	277	138	8	gudmap_developingGonad_e12.5_ovary_k3_1000
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000	AFF3 TRPS1 ASH1L JMJD1C TET1 MID1 NAV2 NKTR	5.13e-04	281	138	8	gudmap_developingGonad_e18.5_epididymis_1000_k3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3	TRPS1 ASH1L ZFP37 DDX50 N4BP1 CLSPN HEATR5B SLX4	6.45e-04	291	138	8	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_500	AFF3 TRPS1 RNF213 REV3L	6.69e-04	61	138	4	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k3_500
CoexpressionAtlas	DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_500	PHACTR2 REV3L ZNF551 CEP350 SCMH1 RBFOX2	6.96e-04	163	138	6	gudmap_developingKidney_e15.5_cortic collect duct_500_k4
CoexpressionAtlas	dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000	CACNB2 MAP1A AFF3 TRPS1 MUC16 RNF213 S1PR3 ZFP37 RESF1 SCMH1 NAV2 AFF1 FLRT3 ANKRD45	7.01e-04	797	138	14	gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000	BCLAF1 AFF3 TRPS1 ASH1L JMJD1C ZNF462 KMT2C RESF1 SCMH1 TET1 MID1 NAV2 NKTR RBFOX2	7.18e-04	799	138	14	gudmap_developingGonad_e18.5_epididymis_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4	CASP8AP2 CWF19L2 MAP1B BCLAF1 PCLO CHD1 DMD CLSPN	7.52e-04	298	138	8	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4
CoexpressionAtlas	dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_1000	CACNB2 AFF3 RNF213 REV3L RESF1 NAV2 AFF1	7.99e-04	231	138	7	gudmap_dev gonad_e11.5_M_GonMes_Sma_k4_1000
CoexpressionAtlas	DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#4_top-relative-expression-ranked_1000	CACNB2 RNF213 WNK1 PCNX2 KMT2C SCAPER	8.15e-04	168	138	6	gudmap_developingGonad_P2_ovary_1000_k4
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	PPP1R12B AFF3 TRPS1 KMT2C SCMH1 SCAPER KCNMA1 AFF1 NR3C2 LIMCH1 MAML2 DMD RBFOX2	1.65e-13	199	149	13	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	BCLAF1 ASH1L RNF213 CHD1 TRIP12 JMJD1C CEP350 BPTF KMT2C RESF1 HELZ NKTR	3.98e-12	200	149	12	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	AFF3 SCMH1 SCAPER NAV2 NR3C2 TANC1 LIMCH1 MAML2 DMD KIF13A RBFOX2	7.37e-11	198	149	11	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	AFF3 HIVEP3 SCMH1 SCAPER NAV2 NR3C2 LIMCH1 MAML2 DMD RBFOX2	1.26e-09	196	149	10	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	CACNB2 ANK2 PPP1R12B CMYA5 FRY SPHKAP MITF LIMCH1 DMD	1.31e-08	185	149	9	6baccb26f999145e51b91d94315bf8d4655bef31
ToppCell	human_hepatoblastoma-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	EXPH5 GRIN2A ZNF462 FBXL7 MITF KCNMA1 NAV2 TANC1 MAML2	1.51e-08	188	149	9	b070a0667f1ee9b825b267b6c389b7c42fc436f9
ToppCell	LV-04._Ventricular_Cardiomyocyte_I\|LV / Chamber and Cluster_Paper	CACNB2 ANK2 PPP1R12B CMYA5 FRY SPHKAP MITF TANC1 LIMCH1	1.81e-08	192	149	9	ad19e2c1d36a0566c9b12ced10db78f4781c8ea6
ToppCell	RA-03._Atrial_Cardiomyocyte\|RA / Chamber and Cluster_Paper	CACNB2 ANK2 PPP1R12B CMYA5 FRY ZNF608 MITF TANC1 DMD	1.98e-08	194	149	9	c3535f7cc0076653c72db582047cff053c322397
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B PCLO ASH1L REV3L KMT2C SPHKAP SCAPER NAV2 NKTR	2.07e-08	195	149	9	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B PCLO ASH1L REV3L KMT2C SPHKAP SCAPER NAV2 NKTR	2.07e-08	195	149	9	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	PHACTR2 MAP1B BCLAF1 PPP1R12B PCLO REV3L CEP350 BPTF LIMCH1	2.47e-08	199	149	9	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ASH1L ARHGEF12 RNF213 ITPRID2 BPTF KMT2C RESF1 ZNF608 NKTR	2.58e-08	200	149	9	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	BCLAF1 RNF213 CHD1 DNTTIP2 TGOLN2 BPTF KMT2C RESF1 N4BP1	2.58e-08	200	149	9	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	Calu_3-infected\|Calu_3 / Cell line, Condition and Strain	TRIM25 ASH1L RNF213 TRIP12 JMJD1C CEP350 KMT2C N4BP1	1.96e-07	183	149	8	8f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	CACNB2 ANK2 PPP1R12B CMYA5 FRY MITF LIMCH1 DMD	2.05e-07	184	149	8	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	LA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	CACNB2 ANK2 PPP1R12B AFF3 CMYA5 MITF TANC1 DMD	2.41e-07	188	149	8	6d249fe92d51a19da19ec14bb2262d394255d577
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	BCLAF1 ASH1L USP24 RNF213 CHD1 JMJD1C KMT2C NKTR	2.41e-07	188	149	8	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	CACNB2 ANK2 PPP1R12B CMYA5 SPHKAP MITF LIMCH1 DMD	2.51e-07	189	149	8	5e80c47f63980904c4c1ff02c201b67b456a0974
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	EXPH5 USP24 WNK1 LRP1B MITF NAV2 NR3C2 LIMCH1	2.51e-07	189	149	8	975c0f079903ae36b0ffa54e86294d42ec7697de
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	CACNB2 ANK2 PPP1R12B CMYA5 SPHKAP MITF LIMCH1 DMD	2.61e-07	190	149	8	de5ef606a002f85c2e0e3a36c1f259d0b85a76ff
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	AFF3 PLEKHG1 ZNF608 NR3C2 TANC1 KIF13A DISP1 LRRC36	2.61e-07	190	149	8	474cbbab8f3b0a6881fa6c92edb78e43999f9ab0
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|RV / Chamber and Cluster_Paper	CACNB2 ANK2 PPP1R12B CMYA5 SPHKAP MITF LIMCH1 DMD	2.61e-07	190	149	8	fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|LV / Chamber and Cluster_Paper	CACNB2 ANK2 PPP1R12B CMYA5 SPHKAP MITF LIMCH1 DMD	2.72e-07	191	149	8	25f3eb34f4e70761e81e84c8a5829f216108cbc6
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TSHZ3 NPY1R AFF3 TRPS1 S1PR3 FBXL7 KCNMA1 NAV2	2.72e-07	191	149	8	c54c420a94dc749ebc67fc64c5614663f4b9798d
ToppCell	LA-03._Atrial_Cardiomyocyte\|LA / Chamber and Cluster_Paper	CACNB2 ANK2 PPP1R12B CMYA5 SPHKAP MITF TANC1 DMD	2.72e-07	191	149	8	5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TSHZ3 NPY1R AFF3 TRPS1 S1PR3 FBXL7 KCNMA1 NAV2	2.72e-07	191	149	8	cb0aee740b08f7d5fdd2717ecf7429043b277ae7
ToppCell	LA\|World / Chamber and Cluster_Paper	MAP1B AFF3 LRP1B PCNX2 NWD2 NAV2 MAML2 PRG4	2.94e-07	193	149	8	d4bf89437216baf489ea0239136dcedf3b6714af
ToppCell	RA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	CACNB2 ANK2 PPP1R12B CMYA5 ZNF608 MITF TANC1 DMD	3.06e-07	194	149	8	89812fb164065041357bb37a3c2d87028ec3de4e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CACNB2 MAP1B PPP1R12B AFF3 FRY FBXL7 KCNMA1 DMD	3.06e-07	194	149	8	5c3b2b05d1e4f146551fe4c920263d8e6ca34de3
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CACNB2 MAP1B PPP1R12B AFF3 FRY FBXL7 KCNMA1 DMD	3.06e-07	194	149	8	ab9cad697f9209d2889bc02b43b502dfeb2ebfef
ToppCell	COVID-19-Heart-CM_2\|Heart / Disease (COVID-19 only), tissue and cell type	CACNB2 ANK2 PPP1R12B CMYA5 FRY SPHKAP MITF DMD	3.18e-07	195	149	8	75fc81bddb246dca3b437fb60827b1d4fe416405
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B BCLAF1 ASH1L CHD1 CMYA5 JMJD1C KCNMA1 NKTR	3.18e-07	195	149	8	5c86fddd6d0530beecf45ea5ba6b823123847696
ToppCell	Somatosensory_Cortex_(S1)-Neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MAP1B PCLO AFF3 GRIN2A FRY KCNMA1 ELMOD1 RBFOX2	3.58e-07	198	149	8	c01091ef18e096d792ea2a7a715764a5b215355f
ToppCell	primary_auditory_cortex_(A1C)-Neuronal\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MAP1B PCLO AFF3 GRIN2A FRY KCNMA1 ELMOD1 RBFOX2	3.58e-07	198	149	8	6d18b45eda4014759e6dd282d78ffd28df8a6044
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MAP1B PCLO AFF3 GRIN2A FRY KCNMA1 ELMOD1 RBFOX2	3.58e-07	198	149	8	8ab40fae14fe02e39bc8c8da187a5cd60c787643
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MAP1B PCLO AFF3 GRIN2A FRY KCNMA1 ELMOD1 RBFOX2	3.58e-07	198	149	8	4ca5ff320905ab4ff60ed90a5522227c782142a6
ToppCell	COVID-19-kidney-Fibroblast-1\|kidney / Disease (COVID-19 only), tissue and cell type	NPY1R MAP1B GRIN2A REV3L ADGRE2 S1PR3 NAV2 DMD	3.72e-07	199	149	8	9503646ff1ad248181146ce767e9d12e882ec3bd
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Cap\|LPS_only / Treatment groups by lineage, cell group, cell type	AFF3 ARHGEF12 RNF213 FRY RESF1 TANC1 DISP1 LRRC36	3.86e-07	200	149	8	432384faeade8e609154fab3d96c955a8ec868dd
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	WNK1 LRP1B ANKRD34B RP1L1 MID1 NR3C2 LIMCH1	8.58e-07	153	149	7	9b6675ace8a83c8d446b722301d0ec4e6840f3fc
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B-B_naive-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	PLEKHF2 AFF3 EFCAB13 PLEKHG1 ZNF608 NAV2 DMD	1.42e-06	165	149	7	8003fd2aa3f5c9d0e99054af4ad2d79a4a3c4829
ToppCell	COVID-19_Moderate-B_intermediate\|COVID-19_Moderate / disease group, cell group and cell class	ANK2 AFF3 PLEKHG1 ZNF608 ZNF534 DMD PARP15	2.27e-06	177	149	7	68e3d12a0c048a2d0f1b9680c7338a35855bba30
ToppCell	TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-5\|TCGA-Skin / Sample_Type by Project: Shred V9	MAP1A TRPS1 LRP1B FAM135B ZFP37 PCNX2 FLRT3	2.36e-06	178	149	7	ad5cd505ca1cef8ac29b2af7e2c3e01ebc140c14
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	USP17L2 EXPH5 USP24 WNK1 MID1 NR3C2 LIMCH1	2.45e-06	179	149	7	666072c0e8448dbaec1683d18368ec2502453f90
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	EXPH5 USP24 WNK1 MITF NR3C2 LIMCH1 MAML2	2.73e-06	182	149	7	5f513bbb7125956eb528e3120de3fd776770a7c3
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B AFF3 GRIN2A ADGRG4 NAV3 NAV2 DMD	2.93e-06	184	149	7	e061e85c4bb19f49f6451ddd7a9077d7378ee365
ToppCell	COVID-19-Heart-CM_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNB2 ANK2 PPP1R12B CMYA5 FRY SPHKAP DMD	3.04e-06	185	149	7	549eeb521c3985bff396ea0f202db21822efa51f
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PCLO MUC16 LRP1B JMJD1C KMT2C C18orf63 KCNMA1	3.15e-06	186	149	7	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	COVID-19-kidney-Fibroblast-1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NPY1R MAP1B GRIN2A REV3L ADGRE2 NAV2 DMD	3.27e-06	187	149	7	76bfe8c42430a230a8bdf299575c444fb7780f24
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	USP24 LRP1B FAM83B MITF KCNMA1 NR3C2 LIMCH1	3.27e-06	187	149	7	f124d2c699b717b7c02a1a70493f515b83dc2f4c
ToppCell	LA-13._Vascular_Smooth_Muscle\|LA / Chamber and Cluster_Paper	CACNB2 PPP1R12B FRY MID1 KCNMA1 DMD KIF13A	3.38e-06	188	149	7	34e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	EXPH5 USP24 WNK1 MITF NR3C2 LIMCH1 MAML2	3.38e-06	188	149	7	bc089cd73d283ed7d2ecbb3936673b4edc89f666
ToppCell	COVID-19-kidney-DCT\|kidney / Disease (COVID-19 only), tissue and cell type	USP24 WNK1 LRP1B FAM83B NAV2 NR3C2 LIMCH1	3.38e-06	188	149	7	df1fd0819d301679f3c9ea404e942e39095912eb
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	EXPH5 USP24 WNK1 MITF NR3C2 LIMCH1 MAML2	3.38e-06	188	149	7	eec3d353e51358db4c7621265ee0fdd4298e5b0e
ToppCell	droplet-Lung-18m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CCDC60 CFAP43 ADGB LRGUK LIAT1 ANKRD45 ELMOD1	3.38e-06	188	149	7	0eca3dc93724e23b71e687fc24fa9f1e89bdef6a
ToppCell	droplet-Lung-18m-Epithelial-airway_epithelial-lung_ciliated_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CCDC60 CFAP43 ADGB LRGUK LIAT1 ANKRD45 ELMOD1	3.38e-06	188	149	7	9ce3e1fffce87ad19812ecbf9b7f9935a975d676
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NPY1R AFF3 GRIN2A FBXL7 NAV2 TANC1 DMD	3.50e-06	189	149	7	71397e993a77d70b2eeede240bdfc7660b558987
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NPY1R AFF3 GRIN2A FBXL7 NAV2 TANC1 DMD	3.50e-06	189	149	7	4eea4759520c312bd17a681034d8074e47093d2b
ToppCell	RV-04._Ventricular_Cardiomyocyte_I\|RV / Chamber and Cluster_Paper	CACNB2 ANK2 PPP1R12B CMYA5 FRY SPHKAP MITF	3.50e-06	189	149	7	9c1debd65c13d63fd4f3158917d621b44b714c26
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NPY1R EXPH5 USP24 WNK1 MITF NR3C2 MAML2	3.50e-06	189	149	7	977a813e5d7a5a561c1fced2bbf21c20056b88d8
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TSHZ3 ZNF608 SPHKAP MID1 MITF NAV2 TANC1	3.50e-06	189	149	7	06c44746fa4f02e6e2b3b635cdf2d8dfef3754d3
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PHACTR2 WNK1 LRP1B MID1 MITF NR3C2 LIMCH1	3.50e-06	189	149	7	90aae7e806882bebfad78a78e9a16cf56af3ecd4
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CACNB2 MAP1B PPP1R12B AFF3 FRY KCNMA1 DMD	3.50e-06	189	149	7	127ad2ba3e794df8cce2eee3e4171bccb5aad51b
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	EXPH5 PCLO PLEKHG1 FRY MTMR7 GKAP1 DMD	3.50e-06	189	149	7	7659c7bbd58ee959a159294fb8d17317bbcc5681
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	EXPH5 USP24 WNK1 MITF NAV2 NR3C2 LIMCH1	3.50e-06	189	149	7	7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CACNB2 MAP1B PPP1R12B AFF3 FRY KCNMA1 DMD	3.50e-06	189	149	7	2cfb4d12f75678d1619f4743838a0e954bd57761
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	USP24 LRP1B FAM83B MITF KCNMA1 NR3C2 LIMCH1	3.50e-06	189	149	7	e32172ad09e93f6ac6ea2b92145b2b73003f7970
ToppCell	droplet-Lung-18m-Epithelial-airway_epithelial\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CCDC60 CFAP43 ADGB LRGUK LIAT1 ANKRD45 ELMOD1	3.50e-06	189	149	7	fe958fdf9963c2dfe270f67f0da36b3264d0017c
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TSHZ3 NPY1R AFF3 S1PR3 FBXL7 KCNMA1 NAV2	3.50e-06	189	149	7	c734e5693808a0333139e87bd5be2597a9252afe
ToppCell	COVID-19-Heart\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ANK2 MAP1B CMYA5 FRY FBXL7 SPHKAP DMD	3.63e-06	190	149	7	918ad5037881212008f9f69d5df5da91fd01422c
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CACNB2 MAP1B PPP1R12B KCNMA1 NAV3 DMD ELMOD1	3.63e-06	190	149	7	562ee3b025c29edf07b8b344323edb49d82f1c7e
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CACNB2 MAP1B PPP1R12B KCNMA1 NAV3 DMD ELMOD1	3.63e-06	190	149	7	f5fb989afabb49d64d91324570cd8c80a4b9e67d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	EXPH5 USP24 WNK1 MITF NR3C2 LIMCH1 MAML2	3.63e-06	190	149	7	e252e925600e6457fa6e362a55217f4cffa75cdb
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TSHZ3 NPY1R AFF3 S1PR3 FBXL7 KCNMA1 NAV2	3.75e-06	191	149	7	806b94f567ea09a9f443cd4091e70cdb1253ac08
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NPY1R AFF3 GRIN2A FBXL7 NAV3 NAV2 DMD	3.89e-06	192	149	7	5105e4b577408b4e1a62d0a44c23c2b830ccad88
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NPY1R MAP1B AFF3 GRIN2A FBXL7 NAV3 DMD	3.89e-06	192	149	7	d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	ASH1L RNF213 CHD1 JMJD1C KMT2C NKTR MAML2	3.89e-06	192	149	7	47646d7e4990be85072987f92bf18d52f8da752e
ToppCell	PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ANK2 EXPH5 PCLO PLEKHG1 FRY MTMR7 DMD	3.89e-06	192	149	7	b99f8236ef4ccdc75c02abea381cae6453205f6f
ToppCell	NS-moderate-d_0-4\|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CCDC60 ABCA13 EXPH5 CFAP43 ADGB ZNF608 ANKRD45	4.02e-06	193	149	7	ea345d34440b25f65358a53dc72831998d1c3620
ToppCell	COVID-19-Fibroblasts-Other_FB\|COVID-19 / group, cell type (main and fine annotations)	CACNB2 MAP1B FBXL7 NAV3 LIMCH1 DMD RBFOX2	4.02e-06	193	149	7	e6b75be08e33c1de079fb5c02f0b4468128b369c
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TSHZ3 ZNF608 SPHKAP MITF NAV2 TANC1 LRRC36	4.02e-06	193	149	7	8b77625bf3c87d39767fb391d1beaca4ab02342b
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TSHZ3 NPY1R AFF3 GRIN2A NAV2 TANC1 DMD	4.16e-06	194	149	7	81713e0409e8be695ba5dfdc67a997b33435dd9e
ToppCell	PCW_07-8.5-Epithelial\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	EXPH5 PCLO PLEKHG1 FRY MTMR7 GKAP1 LRRC36	4.16e-06	194	149	7	f63ceedb88a9abc8644ee94adfd541e7817c1e3a
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B PPP1R12B AFF3 FRY FBXL7 KCNMA1 DMD	4.16e-06	194	149	7	ebb038f94f49f5c655578d1b018676e10c6b7e3c
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TSHZ3 NPY1R AFF3 GRIN2A NAV2 TANC1 DMD	4.16e-06	194	149	7	627cffe2d448e74fc5df92e74e5b922a73304137
ToppCell	COVID-19-Heart-CM_1\|Heart / Disease (COVID-19 only), tissue and cell type	CACNB2 ANK2 PPP1R12B CMYA5 SPHKAP MITF DMD	4.30e-06	195	149	7	f1ef50331eda8f1239dba6ea970df4eaccf032f1
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NPY1R AFF3 GRIN2A FBXL7 NAV3 NAV2 DMD	4.30e-06	195	149	7	3c3703f092b6fc1b7333426fb5e2823bfb74bb57
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CACNB2 MAP1B AFF3 FRY FBXL7 KCNMA1 DMD	4.45e-06	196	149	7	b8759e6231e0254797d6c30930407b79440c57bb
ToppCell	COPD-Multiplet-Multiplet\|COPD / Disease state, Lineage and Cell class	ABCA13 ARHGEF12 CFAP43 NAV2 TANC1 LIMCH1 CLSPN	4.45e-06	196	149	7	af4cdc61830685a888a1209826c23bcf54a43084
ToppCell	COPD-Multiplet\|COPD / Disease state, Lineage and Cell class	ABCA13 ARHGEF12 CFAP43 NAV2 TANC1 LIMCH1 CLSPN	4.45e-06	196	149	7	6d02d494196e3f857d53eea46d9419690d43beca
ToppCell	COVID-19_Mild\|World / Disease group, lineage and cell class	BCLAF1 RNF213 CHD1 JMJD1C KMT2C N4BP1 NKTR	4.60e-06	197	149	7	5c33454b10023decd2f5ccda9229b6512659711e
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09)	BCLAF1 RNF213 CHD1 JMJD1C KMT2C N4BP1 NKTR	4.76e-06	198	149	7	44417089b62056269cac38d3134ff209c05b7007
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	PHACTR2 BCLAF1 EXPH5 CHD1 DNTTIP2 CEP350 BPTF	4.76e-06	198	149	7	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	BCLAF1 RNF213 CHD1 JMJD1C KMT2C N4BP1 NKTR	4.76e-06	198	149	7	28ef3fc4c17dcb765537b75917f7db78baa522db
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35\|World / Primary Cells by Cluster	ANK2 MAP1B BCLAF1 ZNF462 BPTF ZNF608 RBFOX2	4.76e-06	198	149	7	de5214a85fe017eb23d4aa8af624464f062ec57e
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV-2\|World / Primary Cells by Cluster	TSHZ3 NPY1R ANK2 MAP1B PCLO LIMCH1 ELMOD1	4.92e-06	199	149	7	f09b40245d3d826275bbe5f508dedccc75a911bd
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	CWF19L2 ASH1L USP24 RNF213 BPTF NKTR PARP15	4.92e-06	199	149	7	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV\|World / Primary Cells by Cluster	TSHZ3 NPY1R ANK2 MAP1B PCLO LIMCH1 ELMOD1	4.92e-06	199	149	7	e45448ec4db8875c8aaa9aad109a10e2905a4226
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_\|World / Primary Cells by Cluster	ANK2 MAP1B PCLO AFF3 LIMCH1 ELMOD1 RBFOX2	4.92e-06	199	149	7	058373b4ac3cec2108cb24265628ff0a50646e33
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	MAP1B PCLO AFF3 HIVEP3 LIMCH1 ELMOD1 RBFOX2	5.08e-06	200	149	7	84e4565d28a02700bf7f6730d1b3a58744ca0aea
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2\|Neuronal / cells hierarchy compared to all cells using T-Statistic	TSHZ3 ZNF608 SPHKAP MID1 MITF NAV2 TANC1	5.08e-06	200	149	7	858421b91f5207b7934b5c219752cb9322a3da31
Computational	Genes upregulated in subsets of cells of a given type within various tumors	ASH1L ARHGEF12 RNF213 BPTF NKTR	2.90e-05	50	78	5	GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4
Disease	primary ovarian insufficiency (implicated_via_orthology)	USP17L2 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	5.88e-18	46	149	12	DOID:5426 (implicated_via_orthology)
Disease	congenital heart disease (implicated_via_orthology)	USP17L2 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 KMT2C USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	2.47e-17	69	149	13	DOID:1682 (implicated_via_orthology)
Disease	Neurodevelopmental Disorders	ANK2 ASH1L TRIP12 CDC42BPB HIVEP3 KMT2C	7.96e-06	93	149	6	C1535926
Disease	neuroimaging measurement	ZNF438 CACNB2 MAP1B AFF3 TRPS1 RGPD1 ARHGEF12 REV3L JMJD1C ZNF462 PLEKHG1 CCM2 FBXL7 MITF NAV3 NAV2 AFF1 AKAP10	8.04e-06	1069	149	18	EFO_0004346
Disease	cerebral cavernous malformation (implicated_via_orthology)	RNF213 CDC42BPB CCM2	2.02e-05	11	149	3	DOID:0060669 (implicated_via_orthology)
Disease	brain measurement, neuroimaging measurement	ZNF438 CACNB2 TRPS1 EFCAB13 RGPD1 ZNF462 BPTF FBXL7 MITF NAV3 NAV2 AKAP10	2.45e-05	550	149	12	EFO_0004346, EFO_0004464
Disease	Sarcomatoid Renal Cell Carcinoma	KDM5C RELA LRP1B MITF KCNMA1 NAV3	4.90e-05	128	149	6	C1266043
Disease	Chromophobe Renal Cell Carcinoma	KDM5C RELA LRP1B MITF KCNMA1 NAV3	4.90e-05	128	149	6	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	KDM5C RELA LRP1B MITF KCNMA1 NAV3	4.90e-05	128	149	6	C1266044
Disease	Papillary Renal Cell Carcinoma	KDM5C RELA LRP1B MITF KCNMA1 NAV3	4.90e-05	128	149	6	C1306837
Disease	Renal Cell Carcinoma	KDM5C RELA LRP1B MITF KCNMA1 NAV3	4.90e-05	128	149	6	C0007134
Disease	response to anticonvulsant	CACNB2 ANK2 SYDE2 NAV3 DISP1	7.27e-05	85	149	5	GO_0036277
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	KDM5C RELA LRP1B MITF KCNMA1 NAV3	1.10e-04	148	149	6	C0279702
Disease	alpha fetoprotein measurement	JMJD1C RGS12 TET1 ANKRD17 AFF1	1.57e-04	100	149	5	EFO_0010583
Disease	Colorectal Carcinoma	CACNB2 ANK2 MAP1B ABCA13 CHD1 GRIN2A WNK1 HIVEP3 KMT2C NR3C2 DMD HR	2.45e-04	702	149	12	C0009402
Disease	trait in response to apixaban	GRIN2A ADGRE2 TLE3 PTRH2 DMD	3.02e-04	115	149	5	OBA_2050328
Disease	quality of life during menstruation measurement, breast pressure measurement	MAP1B ANKRD17	3.75e-04	6	149	2	EFO_0009366, EFO_0009393
Disease	Intellectual Disability	MAP1B KDM5C AFF3 ASH1L ZNF462 BPTF KMT2C FRY SCAPER	4.67e-04	447	149	9	C3714756
Disease	eicosapentaenoic acid measurement	TSHZ3 HCG22 NAV2	5.11e-04	31	149	3	EFO_0007760
Disease	electroencephalogram measurement	CMYA5 PCNX2 MITF DMD	5.46e-04	74	149	4	EFO_0004357
Disease	aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement	TRPS1 SCYL1 TRIP12 HIVEP3 BPTF SPHKAP TET1 HR	5.47e-04	364	149	8	EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946
Disease	intellectual disability (implicated_via_orthology)	ANK2 KDM5C ATF7IP2 RBFOX2	5.75e-04	75	149	4	DOID:1059 (implicated_via_orthology)
Disease	neuroticism measurement, cognitive function measurement	PPP1R12B PCLO TRPS1 GRIN2A LRP1B JMJD1C GKAP1 NAV2 AKAP10 NR3C2	6.30e-04	566	149	10	EFO_0007660, EFO_0008354
Disease	neuroimaging measurement, brain volume measurement	CACNB2 TRPS1 RGPD1 BPTF FBXL7 MITF NAV3	6.50e-04	286	149	7	EFO_0004346, EFO_0006930
Disease	triacylglycerol 58:6 measurement	LRP1B HIVEP3	6.95e-04	8	149	2	EFO_0010440
Disease	pseudohypoaldosteronism (is_implicated_in)	WNK1 NR3C2	6.95e-04	8	149	2	DOID:4479 (is_implicated_in)
Disease	clostridium difficile infection	TRPS1 GRIN2A HCG22 NWD2 SCAPER	8.41e-04	144	149	5	EFO_0009130
Disease	eye morphology measurement	ZNF438 PHACTR2 MAP1B FRY NAV3 NR3C2	8.67e-04	218	149	6	EFO_0007858
Disease	influenza A (H1N1)	TRPS1 LRP1B MITF DMD	1.00e-03	87	149	4	EFO_1001488
Disease	corpus callosum anterior volume measurement	TRPS1 NAV3 NAV2	1.01e-03	39	149	3	EFO_0010295
Disease	autism spectrum disorder (implicated_via_orthology)	TSHZ3 KDM5C ASH1L CHD1 NR3C2	1.07e-03	152	149	5	DOID:0060041 (implicated_via_orthology)
Disease	Pseudohypoaldosteronism, Type I	WNK1 NR3C2	1.11e-03	10	149	2	C0268436
Disease	Pseudohypoaldosteronism	WNK1 NR3C2	1.11e-03	10	149	2	C0033805
Disease	Hyperpotassemia and Hypertension, Familial	WNK1 NR3C2	1.11e-03	10	149	2	C2713447
Disease	Pseudohypoaldosteronism, Type I, Autosomal Recessive	WNK1 NR3C2	1.11e-03	10	149	2	C1449843
Disease	Pseudohypoaldosteronism, Type II	WNK1 NR3C2	1.11e-03	10	149	2	C1449844
Disease	Pseudohypoaldosteronism, Type I, Autosomal Dominant	WNK1 NR3C2	1.11e-03	10	149	2	C1449842
Disease	eosinophil percentage of leukocytes	FAM76B CHD1 WNK1 JMJD1C HIVEP3 BPTF CCM2 RESF1 TLE3 GKAP1 N4BP1	1.48e-03	746	149	11	EFO_0007991
Disease	serum alanine aminotransferase measurement	EXPH5 PCLO TRPS1 EFCAB13 CMYA5 RGS12 BPTF RESF1 ZNF827 RP1L1 TET1 RBFOX2	1.58e-03	869	149	12	EFO_0004735
Disease	systolic blood pressure, alcohol consumption measurement	CACNB2 PLEKHG1 RP1L1	1.74e-03	47	149	3	EFO_0006335, EFO_0007878
Disease	alcohol and nicotine codependence	RGPD1 PLEKHG1	1.90e-03	13	149	2	EFO_0004776
Disease	schizophrenia, intelligence, self reported educational attainment	DCAF1 CACNB2 AFF3 GRIN2A LRP1B SPHKAP MAML2	1.94e-03	346	149	7	EFO_0004337, EFO_0004784, MONDO_0005090
Disease	developmental disorder of mental health (implicated_via_orthology)	ASH1L GRIN2A TANC1	1.96e-03	49	149	3	DOID:0060037 (implicated_via_orthology)
Disease	attempted suicide	FAM76B CCDC7 ATF7IP2 NAV3 RBFOX2	2.15e-03	178	149	5	EFO_0004321
Disease	diastolic blood pressure, systolic blood pressure	CACNB2 ANK2 MAP1B TRPS1 SCYL1 CAGE1 RGS12 CEP350 AFF1 NR3C2	2.21e-03	670	149	10	EFO_0006335, EFO_0006336
Disease	Abnormality of refraction	TSHZ3 PCLO FAM76B GRIN2A ZNF462 HIVEP3 FRY ZNF608 KCNMA1 AFF1	2.29e-03	673	149	10	HP_0000539
Disease	episodic memory	GRIN2A CEP350 ATF7IP2	2.33e-03	52	149	3	EFO_0004333
Disease	interleukin 12 measurement	EFCAB13 JMJD1C ZNF462	2.46e-03	53	149	3	EFO_0004753
Disease	serum selenium measurement	FAM135B MTMR7 KIF13A	2.46e-03	53	149	3	EFO_0005266
Disease	hepcidin:transferrin saturation ratio	MUC16 ZNF551	2.55e-03	15	149	2	EFO_0007902
Disease	atrial fibrillation	FAM76B JMJD1C CCDC7 ZNF462 SCMH1 TLE3 NAV2	2.87e-03	371	149	7	EFO_0000275
Disease	visceral adipose tissue measurement	TRPS1 GRIN2A WNK1 TRIP12 HIVEP3 BPTF SPHKAP HELZ	3.17e-03	481	149	8	EFO_0004765
Disease	unipolar depression	CASP8AP2 ABCA13 PCLO TRPS1 ASH1L RNF213 ADGRE2 CDC42BPB FAM135B BPTF DDX50 ZNF608 DMD PARP15	3.26e-03	1206	149	14	EFO_0003761
Disease	respiratory symptom change measurement, response to placebo	ATF7IP2 NAV2	3.28e-03	17	149	2	EFO_0008344, EFO_0010068
Disease	adverse effect, response to xenobiotic stimulus	LRP1B FBXL7 NAV2	3.34e-03	59	149	3	EFO_0009658, GO_0009410
Disease	cortical surface area measurement	ZNF438 PPP1R12B PPFIA1 RGPD1 ARHGEF12 FAM76B TGOLN2 PLEKHG1 FBXL7 RP1L1 NAV3 NAV2 AFF1 AKAP10 NR3C2	3.40e-03	1345	149	15	EFO_0010736
Disease	body fat percentage	TRPS1 SCYL1 TRIP12 HIVEP3 BPTF SPHKAP TET1 HR	3.46e-03	488	149	8	EFO_0007800
Disease	triglycerides in small VLDL measurement	JMJD1C BPTF AFF1	3.67e-03	61	149	3	EFO_0022145
Disease	response to clozapine	ZNF438 CACNB2	3.67e-03	18	149	2	GO_0097338
Disease	level of Sphingomyelin (d34:1) in blood serum	USP24 ANKRD17	3.67e-03	18	149	2	OBA_2045175
Disease	white matter microstructure measurement	CACNB2 PLEKHG1 BPTF CCM2 FBXL7 SCAPER NAV2	3.77e-03	390	149	7	EFO_0005674
Disease	triglycerides in small HDL measurement	JMJD1C BPTF AFF1	3.84e-03	62	149	3	EFO_0022158
Disease	phospholipids in large VLDL measurement	JMJD1C BPTF AFF1	3.84e-03	62	149	3	EFO_0022169
Disease	triglycerides to total lipids in very large HDL percentage	JMJD1C BPTF AFF1	3.84e-03	62	149	3	EFO_0022339
Disease	mean arterial pressure	CWF19L2 CACNB2 ARHGEF12 RNF213 TRIP12 HIVEP3 PLEKHG1 KCNMA1	3.96e-03	499	149	8	EFO_0006340
Disease	cortical thickness	ZNF438 TRPS1 ARHGEF12 JMJD1C ZNF462 PLEKHG1 FBXL7 MITF NAV3 NAV2 AFF1 AKAP10 KIF13A	4.32e-03	1113	149	13	EFO_0004840
Disease	keratoconus	FAM76B LRP1B MAML2	4.58e-03	66	149	3	MONDO_0015486
Disease	pulse pressure measurement	ZNF438 CWF19L2 CACNB2 ANK2 MAP1B TRPS1 EFCAB13 ARHGEF12 FAM76B RNF213 HIVEP3 PLEKHG1 FBXL7 ZNF827 TET1	4.67e-03	1392	149	15	EFO_0005763
Disease	tuberculosis	ZNF438 RGS12 LPCAT2 NAV3 DMD	4.90e-03	216	149	5	MONDO_0018076
Disease	osteoarthritis, hip, osteoarthritis, knee, total joint arthroplasty	KCNMA1 MAML2	4.99e-03	21	149	2	EFO_0004616, EFO_0010726, EFO_1000786

Protein segments in the cluster

Peptide	Gene	Start	Entry
DESPKLKSSSETSVH	AFF3	246	P51826
DHTKDASKASPSVST	ARID3B	156	Q8IVW6
GKKPSLTSESSIHTI	ASH1L	651	Q9NR48
ISKQKTHSETTSVVP	CFAP43	1316	Q8NDM7
SKSKLLQTSVSVHPD	ELMOD1	61	Q8N336
TKDTKTTHSNLLPDC	CAGE1	581	Q8TC20
KSPSETHDKSLTTVS	CCDC7	526	Q96M83
HTLSSSAKADTSKPS	ADGRE2	806	Q9UHX3
DETTPSHISANKLTT	ADGRG4	1211	Q8IZF6
SEKGLSSQSSKHILS	ADGB	1176	Q8N7X0
VSPSKKHETTASFLT	AKAP10	186	O43572
LTKDHQTTGSPSRKT	FLRT3	396	Q9NZU0
TTPCQVKSAKSVTSH	ANKRD45	241	Q5TZF3
HSTLQGTVKSSKDTD	ABCA13	4686	Q86UQ4
SKKTEELSSSQTLSH	GKAP1	191	Q5VSY0
PHSKTISESELSASA	CCM2	281	Q9BSQ5
HSKKTAALQSATPVE	DMD	2056	P11532
AISSASTHKTIKNPV	ANKRD17	1856	O75179
IVSSSKSALHSSVPK	BPTF	1371	Q12830
SDKRSTSHLPTSVEK	CASP8AP2	206	Q9UKL3
SKKSSVSDAPVHITA	CHD1	1381	O14646
HALSTSPSDKGQSKT	DISP1	1156	Q96F81
SVEPVKKSQHRSSSS	CACNB2	521	Q08289
SHDFDPTDSSSKKTK	ARHGEF12	41	Q9NZN5
DSKHTFSPVIKLSTV	ARHGEF12	1071	Q9NZN5
KPQSHSLSTSGKSEV	ARHGEF12	1191	Q9NZN5
SSTSAESHIQPVQKK	CCDC60	351	Q8IWA6
SDSTESNEATPSKKH	NWD2	1706	Q9ULI1
SENSESKSTPKRLHV	RBFOX2	111	O43251
PVKESHSTTTEKANI	KIAA1107	1106	Q9UPP5
AKTERHSPASSSSKT	ANK2	1861	Q01484
IKTASSPLSHSSETE	ANKRD34B	191	A5PLL1
PNSVSSLTDKSKHKT	MUC16	3376	Q8WXI7
GVNSSSKISTPDHDK	MUC16	5226	Q8WXI7
SEVTTDTEKTHPSSN	MUC16	8041	Q8WXI7
ETSTSQEIHSATKPS	MUC16	9006	Q8WXI7
GHKTSSRVNSTTKPE	DCAF1	246	Q9Y4B6
FSSQHSTPSLKTVKV	PARP15	431	Q460N3
LSDKHSPQKKSTVTN	KMT2C	2806	Q8NEZ4
PKSSKSDHISTRSIA	LRP1B	4431	Q9NZR2
SSFSVPIKQESTKHS	NR3C2	421	P08235
PIKQESTKHSCSGTS	NR3C2	426	P08235
DKSSHSSKVPEASKS	MAP1A	1926	P78559
SSKVPEASKSHATTE	MAP1A	1931	P78559
AVKEKTATCHSSSSP	MAP1B	1806	P46821
SQSSSKKSSSVHSIP	KCNMA1	1196	Q12791
KSKQSEPSKHSGFST	MTMR7	556	Q9Y216
KLNTSVDTHKIKSSP	JMJD1C	626	Q15652
THRTKSIKEETPDSA	HR	726	O43593
SIHKSKEDVTVSPSQ	FAM83B	841	Q5T0W9
SDSSPSHKKGESKQQ	PCLO	1741	Q9Y6V0
TIEKSHSSPGSSKSS	PCLO	4871	Q9Y6V0
QTNLDPSSCKSSHEK	PCNX2	511	A6NKB5
SSEVPTTVHEKTQSK	KIAA0232	236	Q92628
SIKPSNDIKTTASHS	LRRC36	361	Q1X8D7
STKEATTSKHIPQTD	NAV3	2326	Q8IVL0
GDKKHSNQKPSETST	CWF19L2	426	Q2TBE0
TPLKSSHENEQSKKS	CYLC1	161	P35663
SSNSSQDSLHKAPKK	PPFIA1	786	Q13136
SSSSSLTEKDQHHPK	FAM76B	156	Q5HYJ3
VSESPSKHENSKDVT	EXPH5	1706	Q8NEV8
SALDKSLSSHSEGPK	LMTK2	1241	Q8IWU2
PAKSLATTADVKTSH	LRGUK	606	Q96M69
DKQPITSHLSSDTTT	PHACTR2	271	O75167
DKEPDSDSTKHSTPS	CDC42BPB	1666	Q9Y5S2
PDLSVTVSTKKSHQT	HELZ	266	P42694
NSSELKSVHISTPEK	ITPRID2	431	P28290
SQSISTKHPETSPKD	HCG22	66	E2RYF7
TPSTASNKVSPEKHE	LPCAT2	521	Q7L5N7
KHTKATATAATTTAP	MAML2	91	Q8IZL2
HTDVSKTSLKQASPV	NPY1R	356	P25929
NADSEIKHSTPSPTK	RGPD3	771	A6NKT7
KLNHPSLTESKESTT	ITGB3BP	66	Q13352
STKVSDSPSHIATKT	HEATR5B	1731	Q9P2D3
STDHTPTKAQKNVAT	FBXL7	26	Q9UJT9
TSETKHDTSLKPISV	CA1	36	P00915
HIKLPQASKSTSESF	BCLAF1	591	Q9NYF8
GLPVIKTSSSQHSDK	CMYA5	1471	Q8N3K9
KSETISSSVKTAHFP	CMYA5	2061	Q8N3K9
ESIKHKVSEPSRSSS	CENPJ	771	Q9HC77
VEKPKIHVQSSSDSS	FAM172A	206	Q8WUF8
VSSLDTSTHKSSDNK	DDX50	111	Q9BQ39
TGTSTEKKSTLEPHS	CEP350	1116	Q5VT06
SQELESSTSPSKHSL	CEP350	1981	Q5VT06
SKKALASPSSKSHED	CEP95	206	Q96GE4
HDSKSKPQSLKSSTS	EFCAB13	401	Q8IY85
SPLESHSKAASNSKE	ATF7IP2	521	Q5U623
HSKAASNSKETTPLA	ATF7IP2	526	Q5U623
PSKSTSSHVKQSSNL	MS4A14	336	Q96JA4
SSSLKDSLTDPSHIN	FRY	2021	Q5TBA9
SAKPIHSSDSVKDSQ	CCDC158	1041	Q5M9N0
SSDKTTLHELSTLGK	FAM135B	606	Q49AJ0
STTGDKHFDKSPTKT	SCAPER	76	Q9BY12
TSNTIESHPKDSLHS	SCAPER	321	Q9BY12
SSNNSSHSPKVKEDL	S1PR3	341	Q99500
CPESSKTSKKHHSDT	C18orf63	641	Q68DL7
TSNPTHSSEDVKPKT	LIMCH1	946	Q9UPQ0
TDLLSKSGKTPSNEH	PLEKHF2	131	Q9H8W4
TDKPTGNSKTIDHKS	MUCL3	96	Q3MIW9
KVTGDKSLTTTSSHL	MUCL3	371	Q3MIW9
SNKTIHTSSSIKLSE	PRR14L	886	Q5THK1
NADSEIKHSTPSPTK	RGPD1	761	P0DJD0
ISPTSDSHEKDTSSQ	FAM149B1	36	Q96BN6
QTKDADSTEHSTPSL	KIF13A	1626	Q9H1H9
SPELTTKASKHGSEN	SYDE2	626	Q5VT97
NADSEIKHSTPSPTK	RGPD4	771	Q7Z3J3
ASLTNHSPLDSKKET	SPHKAP	1391	Q2M3C7
HSPLDSKKETSSCQD	SPHKAP	1396	Q2M3C7
SQVSNSDHKSSKSPE	SCYL1	676	Q96KG9
QSKVEKKHLPSDSST	LIAT1	136	Q6ZQX7
SKSDKDVQSSLTHSS	NKTR	501	P30414
TKNSKNDSHPSSDKE	NKTR	896	P30414
HIKVKPTTKSSTNTS	NKTR	926	P30414
PDSSHDVKVLTSKTS	RESF1	516	Q9HCM1
SHSSVGSNIESDSKK	NAV2	1811	Q8IVL1
KKSPKSASSHSDIEE	NAV2	1846	Q8IVL1
PSKTKTTERLLSHSS	TANC1	1621	Q9C0D5
SSSSQLKHKSQTDSP	OSER1	101	Q9NX31
PKSSHSFDTDKVASI	OR8K3	261	Q8NH51
FKVTTPDTSTTQHNK	PRG4	231	Q92954
VNTEKPSIHSSTKTV	SCMH1	251	Q96GD3
PDHSSSRSQKSSSKL	SLX4	1131	Q8IY92
TEPHFILKSSDNTKT	TET1	1816	Q8NFU7
SSTKSNHKDSSIPKQ	AFF1	901	P51825
EHKTTSKASLNPSDT	AGPS	141	O00116
SAASKERTAPHKSNT	CLEC4A	26	Q9UMR7
HTLSPVKAEAAKESS	CLSPN	1286	Q9HAW4
SPKHLKTDDSTSGLT	CLSPN	1316	Q9HAW4
SKAKSLTDPSQESHT	DNTTIP2	166	Q5QJE6
PKSKTSKTHTDTESE	PTRH2	41	Q9Y3E5
LSKSSVSKNHTERDP	RNF213	2666	Q63HN8
AQTTKDSTSKSHPEL	TGOLN2	116	O43493
GKSLLSTKQETTHPE	ZNF567	166	Q8N184
SLHVQDPSSSSKKDL	TRPS1	61	Q9UHF7
PSSSQRADSHKGTSK	ZNF197	271	O14709
ATPKKLDSTQTTHSS	UBN2	816	Q6ZU65
SLGSDHSSVSTPKKL	RGS12	856	O14924
ELKSQPLKSSSSAEH	MITF	26	O75030
HKDAATLEPSSSAKI	REV3L	561	O60673
KLAGHQETSTKSSET	REV3L	836	O60673
RKDTHSPLDSSVTKQ	RP1L1	671	Q8IWN7
ATSSHPNSTSLKAKV	TRIM25	426	Q14258
SSSKKSHTPERFTSQ	MID1	511	O15344
APASKTLTLHTSAKV	USP17L18	261	D6R9N7
TSKGNTPTQKTHLSE	ZNF551	91	Q7Z340
SHSEKTKPEQSLLSL	HIVEP3	511	Q5T1R4
APASKTLTLHTSAKV	USP17L5	261	A8MUK1
APASKTLTLHTSAKV	USP17L13	261	C9JLJ4
KHVEKSISDNSSVSP	ZNF534	146	Q76KX8
APASKTLTLHTSAKV	USP17L19	261	D6RCP7
LKNLTESHTSKSSTP	TSHZ3	851	Q63HK5
TPSSKTKDLGHNDKS	TLE3	296	Q04726
SEESTKRTSHSKLPE	VSTM1	166	Q6UX27
KHTGEDRKTPSESNS	ZNF827	951	Q17R98
SQSSKSPSLSSKQQH	USP24	1136	Q9UPU5
APASKTLTLHTSAKV	USP17L24	261	Q0WX57
SAPQGNSHKETSKSK	ZNF608	91	Q9ULD9
DSHPSSSNTVKKSQT	ZNF462	646	Q96JM2
HATTSTASKVNTSKP	ZNF280C	566	Q8ND82
PSSRSHKVLKTSETA	PLEKHG1	471	Q9ULL1
APASKTLTLHTSAKV	USP17L6P	261	Q6QN14
VPESAHKTTASEAKS	WNK1	1921	Q9H4A3
APASKTLTLHTSAKV	USP17L22	261	D6RA61
QLKSAQSPSTSKAHT	TRIP12	121	Q14669
STDTTKTHPTIKING	RELA	51	Q04206
APASKTLTLHTSAKV	USP17L15	261	C9J2P7
APASKTLTLHTSAKV	USP17L17	261	D6RBQ6
QTGEKHEKSPSLSSS	ZFP37	266	Q9Y6Q3
HEKSPSLSSSTKHEK	ZFP37	271	Q9Y6Q3
SLSSSTKHEKPQACV	ZFP37	276	Q9Y6Q3
HFVSKITSSKPSAVA	ZNF438	241	Q7Z4V0
APASKTLTLHTSAKV	USP17L2	261	Q6R6M4
APASKTLTLHTSAKV	USP17L20	261	D6RJB6
RSTFHSKSTLSEPQK	ZNF181	161	Q2M3W8
APASKTLTLHTSAKV	USP17L11	261	C9JVI0
TSPKTFLESKEELSH	KDM5C	286	P41229
LTTDSTPKKTQAHTQ	N4BP1	421	O75113
RTPHKSQADTTAEKT	PPP1R12B	556	O60237
SKRSKSLLPDHTSDN	GRIN2A	1351	Q12879